KR102479341B1 - Novel compound and organic light emitting device comprising the same - Google Patents
Novel compound and organic light emitting device comprising the same Download PDFInfo
- Publication number
- KR102479341B1 KR102479341B1 KR1020210061611A KR20210061611A KR102479341B1 KR 102479341 B1 KR102479341 B1 KR 102479341B1 KR 1020210061611 A KR1020210061611 A KR 1020210061611A KR 20210061611 A KR20210061611 A KR 20210061611A KR 102479341 B1 KR102479341 B1 KR 102479341B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- layer
- water
- group
- organic layer
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 224
- -1 (naphthyl)phenyl Chemical group 0.000 claims description 63
- 239000011368 organic material Substances 0.000 claims description 41
- 125000003118 aryl group Chemical group 0.000 claims description 36
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 16
- 229910052805 deuterium Inorganic materials 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 12
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- 229910052717 sulfur Inorganic materials 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 7
- 125000001624 naphthyl group Chemical group 0.000 claims description 7
- 239000004305 biphenyl Substances 0.000 claims description 6
- 235000010290 biphenyl Nutrition 0.000 claims description 6
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims description 6
- 125000003914 fluoranthenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC=C4C1=C23)* 0.000 claims description 6
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 claims description 5
- 125000001072 heteroaryl group Chemical group 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 125000000732 arylene group Chemical group 0.000 claims description 4
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 claims description 4
- 125000003960 triphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C3=CC=CC=C3C12)* 0.000 claims description 4
- 125000005509 dibenzothiophenyl group Chemical group 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000004957 naphthylene group Chemical group 0.000 claims description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 2
- IYYZUPMFVPLQIF-UHFFFAOYSA-N dibenzothiophene Chemical compound C1=CC=C2C3=CC=CC=C3SC2=C1 IYYZUPMFVPLQIF-UHFFFAOYSA-N 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 1
- 239000010410 layer Substances 0.000 description 199
- 239000012044 organic layer Substances 0.000 description 196
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 195
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 158
- 238000002360 preparation method Methods 0.000 description 132
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 112
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 108
- MXQOYLRVSVOCQT-UHFFFAOYSA-N palladium;tritert-butylphosphane Chemical compound [Pd].CC(C)(C)P(C(C)(C)C)C(C)(C)C.CC(C)(C)P(C(C)(C)C)C(C)(C)C MXQOYLRVSVOCQT-UHFFFAOYSA-N 0.000 description 108
- 238000003756 stirring Methods 0.000 description 98
- 238000010898 silica gel chromatography Methods 0.000 description 75
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 73
- 239000000706 filtrate Substances 0.000 description 73
- 239000012299 nitrogen atmosphere Substances 0.000 description 73
- 238000005406 washing Methods 0.000 description 62
- 229910000027 potassium carbonate Inorganic materials 0.000 description 56
- 238000002347 injection Methods 0.000 description 46
- 239000007924 injection Substances 0.000 description 46
- 230000015572 biosynthetic process Effects 0.000 description 44
- 238000010992 reflux Methods 0.000 description 44
- 238000003786 synthesis reaction Methods 0.000 description 43
- 239000000203 mixture Substances 0.000 description 39
- 239000000463 material Substances 0.000 description 35
- 238000004519 manufacturing process Methods 0.000 description 31
- 239000007858 starting material Substances 0.000 description 30
- 230000032258 transport Effects 0.000 description 27
- 230000000903 blocking effect Effects 0.000 description 25
- 125000004432 carbon atom Chemical group C* 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 22
- 239000000126 substance Substances 0.000 description 22
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 16
- 230000005525 hole transport Effects 0.000 description 16
- 239000011541 reaction mixture Substances 0.000 description 15
- 239000000758 substrate Substances 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 12
- 101100311330 Schizosaccharomyces pombe (strain 972 / ATCC 24843) uap56 gene Proteins 0.000 description 10
- 238000000151 deposition Methods 0.000 description 10
- 101150018444 sub2 gene Proteins 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- 239000003960 organic solvent Substances 0.000 description 9
- UKSZBOKPHAQOMP-SVLSSHOZSA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 UKSZBOKPHAQOMP-SVLSSHOZSA-N 0.000 description 8
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 125000005843 halogen group Chemical group 0.000 description 8
- 125000000623 heterocyclic group Chemical group 0.000 description 8
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- 125000003342 alkenyl group Chemical group 0.000 description 7
- 125000000753 cycloalkyl group Chemical group 0.000 description 7
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 150000004982 aromatic amines Chemical class 0.000 description 6
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 6
- 229910052796 boron Inorganic materials 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 125000000962 organic group Chemical group 0.000 description 6
- 235000011056 potassium acetate Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 239000002019 doping agent Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- 238000006069 Suzuki reaction reaction Methods 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000010405 anode material Substances 0.000 description 4
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229940125904 compound 1 Drugs 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 150000002431 hydrogen Chemical group 0.000 description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000002877 alkyl aryl group Chemical group 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 125000001769 aryl amino group Chemical group 0.000 description 3
- 125000006267 biphenyl group Chemical group 0.000 description 3
- 239000010406 cathode material Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229920001940 conductive polymer Polymers 0.000 description 3
- 125000004185 ester group Chemical group 0.000 description 3
- 238000004770 highest occupied molecular orbital Methods 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 3
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 3
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 150000003852 triazoles Chemical group 0.000 description 3
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 2
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 2
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 2
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 2
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 2
- OMBVEVHRIQULKW-DNQXCXABSA-M (3r,5r)-7-[3-(4-fluorophenyl)-8-oxo-7-phenyl-1-propan-2-yl-5,6-dihydro-4h-pyrrolo[2,3-c]azepin-2-yl]-3,5-dihydroxyheptanoate Chemical compound O=C1C=2N(C(C)C)C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C(C=3C=CC(F)=CC=3)C=2CCCN1C1=CC=CC=C1 OMBVEVHRIQULKW-DNQXCXABSA-M 0.000 description 2
- UWRZIZXBOLBCON-VOTSOKGWSA-N (e)-2-phenylethenamine Chemical class N\C=C\C1=CC=CC=C1 UWRZIZXBOLBCON-VOTSOKGWSA-N 0.000 description 2
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 2
- SFFSGPCYJCMDJM-UHFFFAOYSA-N 2-[2-(3-oxo-1,2-benzoselenazol-2-yl)ethyl]-1,2-benzoselenazol-3-one Chemical compound [se]1C2=CC=CC=C2C(=O)N1CCN1C(=O)C(C=CC=C2)=C2[se]1 SFFSGPCYJCMDJM-UHFFFAOYSA-N 0.000 description 2
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 2
- LZPWAYBEOJRFAX-UHFFFAOYSA-N 4,4,5,5-tetramethyl-1,3,2$l^{2}-dioxaborolane Chemical compound CC1(C)O[B]OC1(C)C LZPWAYBEOJRFAX-UHFFFAOYSA-N 0.000 description 2
- DDTHMESPCBONDT-UHFFFAOYSA-N 4-(4-oxocyclohexa-2,5-dien-1-ylidene)cyclohexa-2,5-dien-1-one Chemical compound C1=CC(=O)C=CC1=C1C=CC(=O)C=C1 DDTHMESPCBONDT-UHFFFAOYSA-N 0.000 description 2
- ZYASLTYCYTYKFC-UHFFFAOYSA-N 9-methylidenefluorene Chemical compound C1=CC=C2C(=C)C3=CC=CC=C3C2=C1 ZYASLTYCYTYKFC-UHFFFAOYSA-N 0.000 description 2
- ISMDILRWKSYCOD-GNKBHMEESA-N C(C1=CC=CC=C1)[C@@H]1NC(OCCCCCCCCCCCNC([C@@H](NC(C[C@@H]1O)=O)C(C)C)=O)=O Chemical compound C(C1=CC=CC=C1)[C@@H]1NC(OCCCCCCCCCCCNC([C@@H](NC(C[C@@H]1O)=O)C(C)C)=O)=O ISMDILRWKSYCOD-GNKBHMEESA-N 0.000 description 2
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 2
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 2
- 229940126657 Compound 17 Drugs 0.000 description 2
- 229940126639 Compound 33 Drugs 0.000 description 2
- 229940127007 Compound 39 Drugs 0.000 description 2
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 2
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 2
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 2
- RBYGDVHOECIAFC-UHFFFAOYSA-L acetonitrile;palladium(2+);dichloride Chemical compound [Cl-].[Cl-].[Pd+2].CC#N.CC#N RBYGDVHOECIAFC-UHFFFAOYSA-L 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 125000005264 aryl amine group Chemical group 0.000 description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- WDECIBYCCFPHNR-UHFFFAOYSA-N chrysene Chemical compound C1=CC=CC2=CC=C3C4=CC=CC=C4C=CC3=C21 WDECIBYCCFPHNR-UHFFFAOYSA-N 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940126543 compound 14 Drugs 0.000 description 2
- 229940125758 compound 15 Drugs 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 229940125810 compound 20 Drugs 0.000 description 2
- 229940126086 compound 21 Drugs 0.000 description 2
- 229940126208 compound 22 Drugs 0.000 description 2
- 229940125833 compound 23 Drugs 0.000 description 2
- 229940125961 compound 24 Drugs 0.000 description 2
- 229940125846 compound 25 Drugs 0.000 description 2
- 229940125851 compound 27 Drugs 0.000 description 2
- 229940127204 compound 29 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229940125877 compound 31 Drugs 0.000 description 2
- 229940125878 compound 36 Drugs 0.000 description 2
- 229940125807 compound 37 Drugs 0.000 description 2
- 229940127573 compound 38 Drugs 0.000 description 2
- 229940126540 compound 41 Drugs 0.000 description 2
- 229940125936 compound 42 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 2
- 229910052733 gallium Inorganic materials 0.000 description 2
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 2
- 125000005241 heteroarylamino group Chemical group 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 125000005462 imide group Chemical group 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 2
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 2
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- JKDRQYIYVJVOPF-FDGPNNRMSA-L palladium(ii) acetylacetonate Chemical compound [Pd+2].C\C([O-])=C\C(C)=O.C\C([O-])=C\C(C)=O JKDRQYIYVJVOPF-FDGPNNRMSA-L 0.000 description 2
- FVDOBFPYBSDRKH-UHFFFAOYSA-N perylene-3,4,9,10-tetracarboxylic acid Chemical compound C=12C3=CC=C(C(O)=O)C2=C(C(O)=O)C=CC=1C1=CC=C(C(O)=O)C2=C1C3=CC=C2C(=O)O FVDOBFPYBSDRKH-UHFFFAOYSA-N 0.000 description 2
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 2
- 238000005240 physical vapour deposition Methods 0.000 description 2
- 229920000767 polyaniline Polymers 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000004506 ultrasonic cleaning Methods 0.000 description 2
- 238000001771 vacuum deposition Methods 0.000 description 2
- 229910052727 yttrium Inorganic materials 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- 125000000355 1,3-benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical group C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- MYKQKWIPLZEVOW-UHFFFAOYSA-N 11h-benzo[a]carbazole Chemical group C1=CC2=CC=CC=C2C2=C1C1=CC=CC=C1N2 MYKQKWIPLZEVOW-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical group C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000006027 3-methyl-1-butenyl group Chemical group 0.000 description 1
- 125000004920 4-methyl-2-pentyl group Chemical group CC(CC(C)*)C 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910018068 Li 2 O Inorganic materials 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910006404 SnO 2 Inorganic materials 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical group C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005332 alkyl sulfoxy group Chemical group 0.000 description 1
- 125000005377 alkyl thioxy group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 150000003974 aralkylamines Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 125000005165 aryl thioxy group Chemical group 0.000 description 1
- 125000003609 aryl vinyl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Inorganic materials [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- GQVWHWAWLPCBHB-UHFFFAOYSA-L beryllium;benzo[h]quinolin-10-olate Chemical compound [Be+2].C1=CC=NC2=C3C([O-])=CC=CC3=CC=C21.C1=CC=NC2=C3C([O-])=CC=CC3=CC=C21 GQVWHWAWLPCBHB-UHFFFAOYSA-L 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 150000001638 boron Chemical class 0.000 description 1
- 125000005620 boronic acid group Chemical group 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- XOYLJNJLGBYDTH-UHFFFAOYSA-M chlorogallium Chemical compound [Ga]Cl XOYLJNJLGBYDTH-UHFFFAOYSA-M 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 125000002676 chrysenyl group Chemical group C1(=CC=CC=2C3=CC=C4C=CC=CC4=C3C=CC12)* 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000004826 dibenzofurans Chemical class 0.000 description 1
- IYYZUPMFVPLQIF-ALWQSETLSA-N dibenzothiophene Chemical group C1=CC=CC=2[34S]C3=C(C=21)C=CC=C3 IYYZUPMFVPLQIF-ALWQSETLSA-N 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- AOBOMOUUYYHMOX-UHFFFAOYSA-N diethylboron Chemical group CC[B]CC AOBOMOUUYYHMOX-UHFFFAOYSA-N 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- ZTJBELXDHFJJEU-UHFFFAOYSA-N dimethylboron Chemical group C[B]C ZTJBELXDHFJJEU-UHFFFAOYSA-N 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- UCLOAJGCFQIQQW-UHFFFAOYSA-N diphenylboron Chemical group C=1C=CC=CC=1[B]C1=CC=CC=C1 UCLOAJGCFQIQQW-UHFFFAOYSA-N 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005549 heteroarylene group Chemical group 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 229910003437 indium oxide Inorganic materials 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002503 iridium Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- XNUVVHVFAAQPQY-UHFFFAOYSA-L manganese(2+) quinolin-8-olate Chemical compound N1=CC=CC2=CC=CC(=C12)[O-].[Mn+2].N1=CC=CC2=CC=CC(=C12)[O-] XNUVVHVFAAQPQY-UHFFFAOYSA-L 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 150000004866 oxadiazoles Chemical class 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- PENAXHPKEVTBLF-UHFFFAOYSA-L palladium(2+);prop-1-ene;dichloride Chemical compound [Pd+]Cl.[Pd+]Cl.[CH2-]C=C.[CH2-]C=C PENAXHPKEVTBLF-UHFFFAOYSA-L 0.000 description 1
- 150000002964 pentacenes Chemical class 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- 150000005041 phenanthrolines Chemical class 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- XPPWLXNXHSNMKC-UHFFFAOYSA-N phenylboron Chemical group [B]C1=CC=CC=C1 XPPWLXNXHSNMKC-UHFFFAOYSA-N 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 150000003057 platinum Chemical class 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 150000003220 pyrenes Chemical class 0.000 description 1
- 125000001725 pyrenyl group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- CGRKYEALWSRNJS-UHFFFAOYSA-N sodium;2-methylbutan-2-olate Chemical compound [Na+].CCC(C)(C)[O-] CGRKYEALWSRNJS-UHFFFAOYSA-N 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- RFWPGPDEXXGEOQ-UHFFFAOYSA-N tert-butyl(methyl)boron Chemical group C[B]C(C)(C)C RFWPGPDEXXGEOQ-UHFFFAOYSA-N 0.000 description 1
- 229940073455 tetraethylammonium hydroxide Drugs 0.000 description 1
- APBDREXAUGXCCV-UHFFFAOYSA-L tetraethylazanium;carbonate Chemical compound [O-]C([O-])=O.CC[N+](CC)(CC)CC.CC[N+](CC)(CC)CC APBDREXAUGXCCV-UHFFFAOYSA-L 0.000 description 1
- LRGJRHZIDJQFCL-UHFFFAOYSA-M tetraethylazanium;hydroxide Chemical compound [OH-].CC[N+](CC)(CC)CC LRGJRHZIDJQFCL-UHFFFAOYSA-M 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- IBBLKSWSCDAPIF-UHFFFAOYSA-N thiopyran Chemical compound S1C=CC=C=C1 IBBLKSWSCDAPIF-UHFFFAOYSA-N 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- KWQNQSDKCINQQP-UHFFFAOYSA-K tri(quinolin-8-yloxy)gallane Chemical compound C1=CN=C2C(O[Ga](OC=3C4=NC=CC=C4C=CC=3)OC=3C4=NC=CC=C4C=CC=3)=CC=CC2=C1 KWQNQSDKCINQQP-UHFFFAOYSA-K 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- YVTHLONGBIQYBO-UHFFFAOYSA-N zinc indium(3+) oxygen(2-) Chemical compound [O--].[Zn++].[In+3] YVTHLONGBIQYBO-UHFFFAOYSA-N 0.000 description 1
- HTPBWAPZAJWXKY-UHFFFAOYSA-L zinc;quinolin-8-olate Chemical compound [Zn+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 HTPBWAPZAJWXKY-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- H01L51/0067—
-
- H01L51/0073—
-
- H01L51/0074—
-
- H01L51/5012—
-
- H01L51/5072—
-
- H01L51/5092—
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/17—Carrier injection layers
- H10K50/171—Electron injection layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/654—Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6574—Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6576—Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Optics & Photonics (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
본 발명은 신규한 화합물 및 이를 이용한 유기발광 소자를 제공한다. The present invention provides a novel compound and an organic light emitting device using the same.
Description
본 발명은 신규한 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다. The present invention relates to a novel compound and an organic light emitting device including the same.
일반적으로 유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기 발광 현상을 이용하는 유기 발광 소자는 넓은 시야각, 우수한 콘트라스트, 빠른 응답 시간을 가지며, 휘도, 구동 전압 및 응답 속도 특성이 우수하여 많은 연구가 진행되고 있다. In general, the organic light emitting phenomenon refers to a phenomenon in which electrical energy is converted into light energy using an organic material. An organic light emitting device using an organic light emitting phenomenon has a wide viewing angle, excellent contrast, and a fast response time, and has excellent luminance, driving voltage, and response speed characteristics, and thus many studies are being conducted.
유기 발광 소자는 일반적으로 양극과 음극 및 상기 양극과 음극 사이에 유기물층을 포함하는 구조를 가진다. 상기 유기물층은 유기 발광 소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 등으로 이루어질 수 있다. 이러한 유기 발광 소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. An organic light emitting device generally has a structure including an anode, a cathode, and an organic material layer between the anode and the cathode. In order to increase the efficiency and stability of the organic light emitting device, the organic material layer is often composed of a multi-layered structure composed of different materials, and may include, for example, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. In the structure of this organic light emitting device, when a voltage is applied between the two electrodes, holes are injected from the anode and electrons from the cathode are injected into the organic material layer, and when the injected holes and electrons meet, excitons are formed. When it falls back to the ground state, it glows.
상기와 같은 유기 발광 소자에 사용되는 유기물에 대하여 새로운 재료의 개발이 지속적으로 요구되고 있다.The development of new materials for organic materials used in the organic light emitting device as described above is continuously required.
본 발명은 신규한 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다. The present invention relates to a novel compound and an organic light emitting device including the same.
본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:The present invention provides a compound represented by Formula 1 below:
[화학식 1] [Formula 1]
상기 화학식 1에서, In Formula 1,
X는 O 또는 S이고,X is O or S;
A는 인접한 두 개의 고리와 융합된 벤젠 고리이며,A is a benzene ring fused with two adjacent rings,
R1 내지 R8 중 어느 하나는 하기 화학식 2로 표시되고, 나머지는 각각 독립적으로 CH 또는 CD이고,Any one of R 1 to R 8 is represented by the following formula (2), and the others are each independently CH or CD;
R은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-60 알킬, 또는 치환 또는 비치환된 C6-60 아릴이며, Each R is independently hydrogen, deuterium, substituted or unsubstituted C 1-60 alkyl, or substituted or unsubstituted C 6-60 aryl;
n은 0 내지 6의 정수이고,n is an integer from 0 to 6;
[화학식 2][Formula 2]
상기 화학식 2에서,In Formula 2,
L은 단일 결합, 또는 치환 또는 비치환된 C6-60 아릴렌이고,L is a single bond or a substituted or unsubstituted C 6-60 arylene;
Y는 각각 독립적으로 N 또는 CH이되, 단 Y중 적어도 2개는 N이고,Y is each independently N or CH, provided that at least two of Y are N,
Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6-60 아릴, 또는 치환 또는 비치환된, N, O 및 S로 구성되는 군으로부터 선택되는 어느 하나 이상을 포함하는 C5-60 헤테로아릴이며,Ar 1 and Ar 2 are each independently a substituted or unsubstituted C 6-60 aryl, or a substituted or unsubstituted C 5-60 hetero including any one or more selected from the group consisting of N, O and S; aryl,
점선은 결합 위치를 나타낸다.Dotted lines indicate binding sites.
또한, 본 발명은 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물 층을 포함하는 유기 발광 소자로서, 상기 유기물 층 중 1층 이상은 상기 화학식 1로 표시되는 화합물을 포함하는, 유기 발광 소자를 제공한다.In addition, the present invention is a first electrode; a second electrode provided to face the first electrode; and one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the compound represented by Chemical Formula 1. to provide.
상술한 화학식 1로 표시되는 화합물은 유기 발광 소자의 유기물 층의 재료로서 사용될 수 있으며, 유기 발광 소자에서 효율의 향상, 낮은 구동전압 및/또는 수명 특성을 향상시킬 수 있다. 특히, 상술한 화학식 1로 표시되는 화합물은 정공주입, 정공수송, 정공주입 및 수송, 발광, 전자수송, 또는 전자주입 재료로 사용될 수 있다.The compound represented by Chemical Formula 1 may be used as a material for an organic layer of an organic light emitting diode, and may improve efficiency, low driving voltage, and/or lifespan characteristics of an organic light emitting diode. In particular, the compound represented by Chemical Formula 1 may be used as a material for hole injection, hole transport, hole injection and transport, light emission, electron transport, or electron injection.
도 1은 기판(1), 양극(2), 유기물 층(3), 및 음극(4)으로 이루어진 유기 발광 소자의 예를 도시한 것이다.
도 2는 기판(1), 양극(2), 정공주입층(5), 정공수송층(6), 전자억제층(7), 발광층(8), 정공저지층(9), 전자 주입 및 수송층(10), 및 음극(4)으로 이루어진 유기 발광 소자의 예를 도시한 것이다.1 shows an example of an organic light emitting device composed of a
2 shows a
이하, 본 발명의 이해를 돕기 위하여 보다 상세히 설명한다.Hereinafter, in order to aid understanding of the present invention, it will be described in more detail.
본 명세서에서, 또는 는 다른 치환기에 연결되는 결합을 의미한다. In this specification, or means a bond connected to another substituent.
본 명세서에서 "치환 또는 비치환된" 이라는 용어는 중수소; 할로겐기; 니트릴기; 니트로기; 히드록시기; 카보닐기; 에스테르기; 이미드기; 아미노기; 포스핀옥사이드기; 알콕시기; 아릴옥시기; 알킬티옥시기; 아릴티옥시기; 알킬술폭시기; 아릴술폭시기; 실릴기; 붕소기; 알킬기; 사이클로알킬기; 알케닐기; 아릴기; 아르알킬기; 아르알케닐기; 알킬아릴기; 알킬아민기; 아랄킬아민기; 헤테로아릴아민기; 아릴아민기; 아릴포스핀기; 또는 N, O 및 S 원자 중 1개 이상을 포함하는 헤테로고리기로 이루어진 군에서 선택된 1개 이상의 치환기로 치환 또는 비치환되거나, 상기 예시된 치환기 중 2 이상의 치환기가 연결된 치환 또는 비치환된 것을 의미한다. 예컨대, "2 이상의 치환기가 연결된 치환기"는 비페닐기일 수 있다. 즉, 비페닐기는 아릴기일 수도 있고, 2개의 페닐기가 연결된 치환기로 해석될 수 있다.In this specification, the term "substituted or unsubstituted" means deuterium; halogen group; nitrile group; nitro group; hydroxy group; carbonyl group; ester group; imide group; amino group; phosphine oxide group; alkoxy group; aryloxy group; Alkyl thioxy group; Arylthioxy group; an alkyl sulfoxy group; aryl sulfoxy groups; silyl group; boron group; an alkyl group; cycloalkyl group; alkenyl group; aryl group; aralkyl group; Aralkenyl group; Alkyl aryl group; Alkylamine group; Aralkylamine group; heteroarylamine group; Arylamine group; Arylphosphine group; Or substituted or unsubstituted with one or more substituents selected from the group consisting of a heterocyclic group containing at least one of N, O, and S atoms, or substituted or unsubstituted with two or more substituents linked to each other among the substituents exemplified above. . For example, "a substituent in which two or more substituents are connected" may be a biphenyl group. That is, the biphenyl group may be an aryl group, and may be interpreted as a substituent in which two phenyl groups are connected.
본 명세서에서 카보닐기의 탄소수는 특별히 한정되지 않으나, 탄소수 1 내지 40인 것이 바람직하다. 구체적으로 하기와 같은 구조를 갖는 것일 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the number of carbon atoms of the carbonyl group is not particularly limited, but is preferably 1 to 40 carbon atoms. Specifically, it may have a structure as follows, but is not limited thereto.
본 명세서에 있어서, 에스테르기는 에스테르기의 산소가 탄소수 1 내지 25의 직쇄, 분지쇄 또는 고리쇄 알킬기 또는 탄소수 6 내지 25의 아릴기로 치환될 수 있다. 구체적으로, 하기와 같은 구조를 갖는 것일 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the ester group may be substituted with an aryl group having 6 to 25 carbon atoms or a straight-chain, branched-chain or cyclic chain alkyl group having 1 to 25 carbon atoms in the ester group. Specifically, it may have a structure as follows, but is not limited thereto.
본 명세서에 있어서, 이미드기의 탄소수는 특별히 한정되지 않으나, 탄소수 1 내지 25인 것이 바람직하다. 하기와 같은 구조를 갖는 것일 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the number of carbon atoms of the imide group is not particularly limited, but is preferably 1 to 25 carbon atoms. It may have a structure as follows, but is not limited thereto.
본 명세서에 있어서, 실릴기는 구체적으로 트리메틸실릴기, 트리에틸실릴기, t-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나 이에 한정되지 않는다. In the present specification, the silyl group is specifically a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, a phenylsilyl group, and the like. but not limited to
본 명세서에 있어서, 붕소기는 구체적으로 디메틸붕소기, 디에틸붕소기, t-부틸메틸붕소기, 디페닐붕소기, 페닐붕소기 등이 있으나 이에 한정되지 않는다.In the present specification, the boron group specifically includes a dimethyl boron group, a diethyl boron group, a t-butylmethyl boron group, a diphenyl boron group, a phenyl boron group, but is not limited thereto.
본 명세서에 있어서, 할로겐기의 예로는 불소, 염소, 브롬 또는 요오드가 있다.In this specification, examples of the halogen group include fluorine, chlorine, bromine or iodine.
본 명세서에 있어서, 상기 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 40인 것이 바람직하다. 일 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 20이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 10이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 6이다. 알킬기의 구체적인 예로는 메틸, 에틸, 프로필, n-프로필, 이소프로필, 부틸, n-부틸, 이소부틸, tert-부틸, sec-부틸, 1-메틸-부틸, 1-에틸-부틸, 펜틸, n-펜틸, 이소펜틸, 네오펜틸, tert-펜틸, 헥실, n-헥실, 1-메틸펜틸, 2-메틸펜틸, 4-메틸-2-펜틸, 3,3-디메틸부틸, 2-에틸부틸, 헵틸, n-헵틸, 1-메틸헥실, 사이클로펜틸메틸, 사이클로헥실메틸, n-옥틸, 이소옥틸, tert-옥틸, 1-메틸헵틸, 2-에틸헥실, 2-프로필펜틸, n-노닐, 2,2-디메틸헵틸, 1-에틸-프로필, 1,1-디메틸-프로필, 이소헥실, 4-메틸헥실, 5-메틸헥실 등이 있으나, 이들에 한정되지 않는다.In the present specification, the alkyl group may be straight-chain or branched-chain, and the number of carbon atoms is not particularly limited, but is preferably 1 to 40. According to one embodiment, the number of carbon atoms of the alkyl group is 1 to 20. According to another exemplary embodiment, the number of carbon atoms of the alkyl group is 1 to 10. According to another exemplary embodiment, the alkyl group has 1 to 6 carbon atoms. Specific examples of the alkyl group include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec-butyl, 1-methyl-butyl, 1-ethyl-butyl, pentyl, n -pentyl, isopentyl, neopentyl, tert-pentyl, hexyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 4-methyl-2-pentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl , n-heptyl, 1-methylhexyl, cyclopentylmethyl, cyclohexylmethyl, n-octyl, isooctyl, tert-octyl, 1-methylheptyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2, 2-dimethylheptyl, 1-ethyl-propyl, 1,1-dimethyl-propyl, isohexyl, 4-methylhexyl, 5-methylhexyl, etc., but is not limited thereto.
본 명세서에 있어서, 상기 알케닐기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나, 2 내지 40인 것이 바람직하다. 일 실시상태에 따르면, 상기 알케닐기의 탄소수는 2 내지 20이다. 또 하나의 실시상태에 따르면, 상기 알케닐기의 탄소수는 2 내지 10이다. 또 하나의 실시상태에 따르면, 상기 알케닐기의 탄소수는 2 내지 6이다. 구체적인 예로는 비닐, 1-프로페닐, 이소프로페닐, 1-부테닐, 2-부테닐, 3-부테닐, 1-펜테닐, 2-펜테닐, 3-펜테닐, 3-메틸-1-부테닐, 1,3-부타디에닐, 알릴, 1-페닐비닐-1-일, 2-페닐비닐-1-일, 2,2-디페닐비닐-1-일, 2-페닐-2-(나프틸-1-일)비닐-1-일, 2,2-비스(디페닐-1-일)비닐-1-일, 스틸베닐기, 스티레닐기 등이 있으나 이들에 한정되지 않는다.In the present specification, the alkenyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 40. According to one embodiment, the alkenyl group has 2 to 20 carbon atoms. According to another exemplary embodiment, the alkenyl group has 2 to 10 carbon atoms. According to another exemplary embodiment, the alkenyl group has 2 to 6 carbon atoms. Specific examples include vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 3-methyl-1- Butenyl, 1,3-butadienyl, allyl, 1-phenylvinyl-1-yl, 2-phenylvinyl-1-yl, 2,2-diphenylvinyl-1-yl, 2-phenyl-2-( naphthyl-1-yl)vinyl-1-yl, 2,2-bis(diphenyl-1-yl)vinyl-1-yl, stilbenyl group, styrenyl group, etc., but is not limited thereto.
본 명세서에 있어서, 사이클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 일 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 30이다. 또 하나의 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 20이다. 또 하나의 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 6이다. 구체적으로 사이클로프로필, 사이클로부틸, 사이클로펜틸, 3-메틸사이클로펜틸, 2,3-디메틸사이클로펜틸, 사이클로헥실, 3-메틸사이클로헥실, 4-메틸사이클로헥실, 2,3-디메틸사이클로헥실, 3,4,5-트리메틸사이클로헥실, 4-tert-부틸사이클로헥실, 사이클로헵틸, 사이클로옥틸 등이 있으나, 이에 한정되지 않는다.In the present specification, the cycloalkyl group is not particularly limited, but preferably has 3 to 60 carbon atoms, and according to an exemplary embodiment, the cycloalkyl group has 3 to 30 carbon atoms. According to another exemplary embodiment, the number of carbon atoms of the cycloalkyl group is 3 to 20. According to another exemplary embodiment, the number of carbon atoms of the cycloalkyl group is 3 to 6. Specifically, cyclopropyl, cyclobutyl, cyclopentyl, 3-methylcyclopentyl, 2,3-dimethylcyclopentyl, cyclohexyl, 3-methylcyclohexyl, 4-methylcyclohexyl, 2,3-dimethylcyclohexyl, 3, 4,5-trimethylcyclohexyl, 4-tert-butylcyclohexyl, cycloheptyl, cyclooctyl, and the like, but are not limited thereto.
본 명세서에 있어서, 아릴기는 특별히 한정되지 않으나 탄소수 6 내지 60인 것이 바람직하며, 단환식 아릴기 또는 다환식 아릴기일 수 있다. 일 실시상태에 따르면, 상기 아릴기의 탄소수는 6 내지 30이다. 일 실시상태에 따르면, 상기 아릴기의 탄소수는 6 내지 20이다. 상기 아릴기가 단환식 아릴기로는 페닐기, 바이페닐기, 터페닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다. 상기 다환식 아릴기로는 나프틸기, 안트라세닐기, 페난트릴기, 파이레닐기, 페릴레닐기, 크라이세닐기, 플루오레닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the aryl group is not particularly limited, but preferably has 6 to 60 carbon atoms, and may be a monocyclic aryl group or a polycyclic aryl group. According to one embodiment, the number of carbon atoms of the aryl group is 6 to 30. According to one embodiment, the number of carbon atoms of the aryl group is 6 to 20. The aryl group may be a phenyl group, a biphenyl group, a terphenyl group, etc. as a monocyclic aryl group, but is not limited thereto. The polycyclic aryl group may be a naphthyl group, anthracenyl group, phenanthryl group, pyrenyl group, perylenyl group, chrysenyl group, fluorenyl group, and the like, but is not limited thereto.
본 명세서에 있어서, 플루오레닐기는 치환될 수 있고, 치환기 2개가 서로 결합하여 스피로 구조를 형성할 수 있다. 상기 플루오레닐기가 치환되는 경우, 등이 될 수 있다. 다만, 이에 한정되는 것은 아니다.In the present specification, the fluorenyl group may be substituted, and two substituents may be bonded to each other to form a spiro structure. When the fluorenyl group is substituted, etc. However, it is not limited thereto.
본 명세서에 있어서, 헤테로고리기는 이종 원소로 O, N, Si 및 S 중 1개 이상을 포함하는 헤테로고리기로서, 탄소수는 특별히 한정되지 않으나, 탄소수 2 내지 60인 것이 바람직하다. 헤테로고리기의 예로는 티오펜기, 퓨란기, 피롤기, 이미다졸기, 티아졸기, 옥사졸기, 옥사디아졸기, 트리아졸기, 피리딜기, 비피리딜기, 피리미딜기, 트리아진기, 아크리딜기, 피리다진기, 피라지닐기, 퀴놀리닐기, 퀴나졸린기, 퀴녹살리닐기, 프탈라지닐기, 피리도 피리미디닐기, 피리도 피라지닐기, 피라지노 피라지닐기, 이소퀴놀린기, 인돌기, 카바졸기, 벤조옥사졸기, 벤조이미다졸기, 벤조티아졸기, 벤조카바졸기, 벤조티오펜기, 디벤조티오펜기, 벤조퓨라닐기, 페난쓰롤린기(phenanthroline), 이소옥사졸릴기, 티아디아졸릴기, 페노티아지닐기 및 디벤조퓨라닐기 등이 있으나, 이들에만 한정되는 것은 아니다.In the present specification, the heterocyclic group is a heterocyclic group containing at least one of O, N, Si, and S as heterogeneous elements, and the number of carbon atoms is not particularly limited, but preferably has 2 to 60 carbon atoms. Examples of the heterocyclic group include a thiophene group, a furan group, a pyrrole group, an imidazole group, a thiazole group, an oxazole group, an oxadiazole group, a triazole group, a pyridyl group, a bipyridyl group, a pyrimidyl group, a triazine group, and an acridyl group. , pyridazine group, pyrazinyl group, quinolinyl group, quinazoline group, quinoxalinyl group, phthalazinyl group, pyridopyrimidinyl group, pyridopyrazinyl group, pyrazinopyrazinyl group, isoquinoline group, indole group , carbazole group, benzoxazole group, benzoimidazole group, benzothiazole group, benzocarbazole group, benzothiophene group, dibenzothiophene group, benzofuranyl group, phenanthroline group, isoxazolyl group, thiadia A zolyl group, a phenothiazinyl group, and a dibenzofuranyl group, but are not limited thereto.
본 명세서에 있어서, 아르알킬기, 아르알케닐기, 알킬아릴기, 아릴아민기 중의 아릴기는 전술한 아릴기의 예시와 같다. 본 명세서에 있어서, 아르알킬기, 알킬아릴기, 알킬아민기 중 알킬기는 전술한 알킬기의 예시와 같다. 본 명세서에 있어서, 헤테로아릴아민 중 헤테로아릴은 전술한 헤테로고리기에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 아르알케닐기 중 알케닐기는 전술한 알케닐기의 예시와 같다. 본 명세서에 있어서, 아릴렌은 2가기인 것을 제외하고는 전술한 아릴기에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 헤테로아릴렌은 2가기인 것을 제외하고는 전술한 헤테로고리기에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 탄화수소 고리는 1가기가 아니고, 2개의 치환기가 결합하여 형성한 것을 제외하고는 전술한 아릴기 또는 사이클로알킬기에 관한 설명이 적용될 수 있다. In the present specification, an aralkyl group, an aralkenyl group, an alkylaryl group, and an aryl group among arylamine groups are the same as the examples of the aryl group described above. In the present specification, the alkyl group among the aralkyl group, the alkylaryl group, and the alkylamine group is the same as the examples of the above-mentioned alkyl group. In the present specification, the description of the heterocyclic group described above may be applied to the heteroaryl of the heteroarylamine. In the present specification, the alkenyl group among the aralkenyl groups is the same as the examples of the alkenyl group described above. In the present specification, the description of the aryl group described above may be applied except that the arylene is a divalent group. In the present specification, the description of the heterocyclic group described above may be applied except that the heteroarylene is a divalent group. In the present specification, the hydrocarbon ring is not a monovalent group, and the description of the aryl group or cycloalkyl group described above may be applied, except that the hydrocarbon ring is formed by combining two substituents.
본 발명은 상기 화학식 1로 표시되는 화합물을 제공한다. The present invention provides a compound represented by
바람직하게는 상기 화학식 1은 하기 화학식 1-1 내지 1-3 중 어느 하나일 수 있다: Preferably,
[화학식 1-1][Formula 1-1]
[화학식 1-2][Formula 1-2]
[화학식 1-3][Formula 1-3]
상기 화학식 1-1 내지 1-3에 있어서,In Formulas 1-1 to 1-3,
X, R1 내지 R8, R 및 n은 앞서 정의한 바와 같다. X, R 1 to R 8 , R and n are as previously defined.
또, 상기 화학식 1에서 바람직하게는 R은 수소 또는 중수소일 수 있으며, n이 2 이상의 정수인 경우, R은 각각 독립적으로 수소 또는 중수소일 수 있다. 보다 바람직하게는 R은 모두 수소일 수 있으며, 이때 n은 6의 정수이다. In addition, in
또, 상기 화학식 1에 있어서, 바람직하게는 R1 및 R2 중 어느 하나가 상기 화학식 2로 표시되고, 나머지는 각각 독립적으로 CH 또는 CD이거나; R3 및 R4 중 어느 하나가 상기 화학식 2로 표시되고, 나머지는 각각 독립적으로 CH 또는 CD이거나; 또는 R5 내지 R7 중 어느 하나가 상기 화학식 2로 표시되고, 나머지는 각각 독립적으로 CH 또는 CD일 수 있다. In addition, in
이때, 상기 화학식 2에 있어서, L은 바람직하게는 단일 결합; 또는 중수소 치환되거나 또는 비치환된 C6-20 아릴렌일 수 있다.In this case, in
보다 바람직하게는 L은 단일 결합, 페닐렌, 또는 나프틸렌일 수 있으며, 구체적으로는 L은 단일 결합이거나, 또는 하기 화학식들로 구성된 군으로부터 선택되는 어느 하나일 수 있다:More preferably, L may be a single bond, phenylene, or naphthylene, and specifically, L may be a single bond or any one selected from the group consisting of the following formulas:
상기 각 화학식에서, 점선은 결합 위치를 나타낸다.In each of the above formulas, the dotted line represents the bonding site.
또, 상기 화학식 2에 있어서, 바람직하게는, Y 중 두 개가 N이고 나머지는 CH이거나, 또는 세 개의 Y 모두가 N일 수 있으며, 보다 바람직하게는 Y는 모두 N일 수 있다.Also, in
또, 상기 화학식 2에 있어서, 바람직하게는, Ar1 및 Ar2는 각각 독립적으로 C6-30 아릴; 또는 N, O 또는 S를 포함하는 C5-30 헤테로아릴이며, 상기 Ar1 및 Ar2는 각각 독립적으로 하나 이상의 중수소, C1-20 알킬, 또는 C6-20 아릴로 치환되거나, 또는 비치환될 수 있다.Also, in
또, 상기 화학식 2에 있어서, 바람직하게는, Ar1 및 Ar2 중 하나는 C6-20 아릴이고, 나머지는 N. O 또는 S를 포함하는 C5-20 헤테로아릴이거나, 또는 Ar1 및 Ar2 둘 모두가 C6-20 아릴일 수 있으며, 이때 상기 Ar1 및 Ar2는 각각 독립적으로 하나 이상의 중수소, C1-18 알킬, 또는 C6-18 아릴로 치환되거나, 또는 비치환될 수 있다.In
보다 바람직하게는, Ar1 및 Ar2는 각각 독립적으로 페닐, 비페닐, 터페닐, 나프틸, 페난쓰레닐, 트리페닐레닐, 플루오란테닐, (나프틸)페닐, (페닐)나프틸, 플루오레닐, 디벤조퓨라닐, 디벤조티오펜일 또는 카르바졸일이며, 상기 Ar1 및 Ar2는 각각 독립적으로 하나 이상의 중수소; 메틸 등의 C1-18 알킬; 또는 페닐 등의 C6-18 아릴로 치환되거나 또는 비치환될 수 있다.More preferably, Ar 1 and Ar 2 are each independently phenyl, biphenyl, terphenyl, naphthyl, phenanthrenyl, triphenylenyl, fluoranthenyl, (naphthyl)phenyl, (phenyl)naphthyl, flu orenyl, dibenzofuranyl, dibenzothiophenyl or carbazolyl, wherein Ar 1 and Ar 2 are each independently one or more deuterium; C 1-18 alkyl such as methyl; Or it may be unsubstituted or substituted with C 6-18 aryl such as phenyl.
보다 바람직하게는 Ar1 및 Ar2는 각각 독립적으로 하기 화학식들로 구성되는 군으로부터 선택되는 어느 하나일 수 있다:More preferably, Ar 1 and Ar 2 may each independently be any one selected from the group consisting of the following formulas:
상기 각 화학식에서, In each of the above formulas,
Z는 NR, O 또는 S이고, Z is NR, O or S;
R, R11 및 R12는 동일하거나 상이하고, 각각 독립적으로 수소, 중수소, C1-18 알킬 또는 C6-18 아릴이고, 바람직하게는 상기 R, R11 및 R12은 동일하거나 상이하고, 수소, 중수소, 메틸, 또는 페닐이며,R, R 11 and R 12 are the same or different and each independently represent hydrogen, deuterium, C 1-18 alkyl or C 6-18 aryl, preferably R, R 11 and R 12 are the same or different, hydrogen, deuterium, methyl, or phenyl;
점선은 결합 위치를 나타낸다.Dotted lines indicate binding sites.
보다 더 바람직하게는 Ar1 및 Ar2 중 어느 하나는 페닐, 비페닐 또는 나프틸이고, 나머지는 페닐, 비페닐, 터페닐, 나프틸, 페난쓰레닐, 트리페닐레닐, 플루오란테닐, (나프틸)페닐, (페닐)나프틸, 플루오레닐, 디벤조퓨라닐, 디벤조티오펜일, 또는 카르바졸일이며, 이때, 상기 Ar1 및 Ar2 는 각각 독립적으로 하나 이상의 중수소, 메틸, 또는 페닐로 치환되거나 또는 비치환될 수 있다.Even more preferably, any one of Ar 1 and Ar 2 is phenyl, biphenyl or naphthyl, and the others are phenyl, biphenyl, terphenyl, naphthyl, phenanthrenyl, triphenylenyl, fluoranthenyl, (naph ethyl) phenyl, (phenyl) naphthyl, fluorenyl, dibenzofuranyl, dibenzothiophenyl, or carbazolyl, wherein Ar 1 and Ar 2 are each independently one or more deuterium, methyl, or It may be substituted or unsubstituted with phenyl.
또, 상기 화학식 1에서, Ar1과 Ar2는 서로 동일한 것일 수도 있고, 또는 서로 상이한 것일 수도 있다. Also, in
상기 화학식 1로 표시되는 화합물의 대표적인 예는 하기와 같다.Representative examples of the compound represented by
. .
한편, 상기 화학식 1로 표시되는 화합물은, 일례로 하기 반응식 1과 같은 제조 방법으로 제조할 수 있다. On the other hand, the compound represented by
[반응식 1][Scheme 1]
상기 반응식 1에서, A, Ar1, Ar2, R1 내지 R8, X, Y, 및 n은 상기 화학식 1에서 정의한 바와 같다.In
또 상기 반응식 1에서, W는 할로겐기 또는 붕소 함유 유기기이다.In
또, 상기 반응식 1에서, R’1 내지 R’8 중 어느 하나는 상기 W와 스즈키 커플링 반응가능한 기이고, 나머지는 각각 독립적으로 CH 또는 CD이다. 구체적으로, 상기 W와 스즈키 커플링 반응가능한 기는 할로겐기 또는 붕소 함유 유기기일 수 있으며, 이 상기 W와는 상이하여, W가 할로겐기이면, 상기 R’1 내지 R’8 중 어느 하나는 붕소 함유 유기기가 되고, W가 붕소 함유 유기기이면, R’1 내지 R’8 중 어느 하나는 할로겐기가 된다. In addition, in
또, 상기 반응식 1에서 W는 할로겐기 또는 붕소 함유 유기기이되, 또, 상기 할로겐기는 구체적으로 클로로 또는 보로모 등이고, 상기 붕소 함유 유기기는, 보론산기, 보론산 에스터기, 또는 보론산 피나콜에스터(boronic acid pinacol ester)기 등일 수 있다.In
구체적으로, 상기 화학식 1로 표시되는 화합물은 모핵 구조를 포함하는 화합물(i)과, 상기 모핵 구조에 결합되며, 트리아진 구조를 갖는 화합물(ii)를 염기 및 팔라듐계 촉매의 존재 하에, 스즈키 커플링 반응(Suzuki coupling reaction)시키는 단계를 포함하는 제조방법에 의해 제조될 수 있다. Specifically, the compound represented by
상기 팔라듐계 촉매로는, 비스(디벤질리덴아세톤)팔라듐(0)(Bis(dibenzylideneacetone)palladium(0); (Pd(dba)2)), 비스(트리-tert-부틸포스핀)팔라듐(0)(bis(tri-tert-butylphosphine)palladium(0), Pd(P-tBuP3)2), 테트라키스-(트리페닐포스핀)팔라듐(0) (tetrakis(triphenylphosphine)palladium(0), Pd(PPh3)4), 트리스(디벤질리덴아세톤)디팔라듐(Tris(dibenzylideneacetone)dipalladium, Pd2(dba)3)), 비스(트리페닐포스핀)팔라듐 클로라이드(Bis(triphenylphosphine)palladium chloride, Pd(PPh3)2Cl2), 비스(아세토니트릴)팔라듐 클로라이드(Bis(acetonitrile)palladium(Ⅱ) chloride, Pd(CH3CN)2Cl2), 팔라듐(Ⅱ) 아세테이트(Palladium(Ⅱ) acetate, Pd(OAc)2), 팔라듐(Ⅱ) 아세틸아세토네이트(Palladium(Ⅱ) acetylacetonate, Pd(acac)2], 알릴팔라듐(Ⅱ) 클로라이드 다이머(Allylpalladium(Ⅱ) chloride dimer, Pd(allyl)Cl]2), 팔라듐 카본(Palladium on carbon, Pd/C), 또는 팔라듐(Ⅱ) 클로라이드(Palladium(Ⅱ) chloride, PdCl2) 등을 들 수 있으며, 이들 중 어느 하나 또는 둘 이상의 혼합물이 사용될 수 있다.As the palladium-based catalyst, bis(dibenzylideneacetone)palladium(0) (Bis(dibenzylideneacetone)palladium(0); (Pd(dba) 2 )), bis(tri-tert-butylphosphine)palladium(0) )(bis(tri-tert-butylphosphine)palladium(0), Pd(P-tBuP 3 ) 2 ), tetrakis-(triphenylphosphine)palladium(0) (tetrakis(triphenylphosphine)palladium(0), Pd( PPh 3 ) 4 ), Tris (dibenzylideneacetone) dipalladium, Pd 2 (dba) 3 )), Bis (triphenylphosphine) palladium chloride, Pd ( PPh 3 ) 2 Cl 2 ), bis(acetonitrile)palladium(II) chloride (Bis(acetonitrile)palladium(II) chloride, Pd(CH 3 CN) 2 Cl 2 ), palladium(II) acetate (Palladium(II) acetate, Pd (OAc) 2 ), Palladium(II) acetylacetonate (Pd(acac) 2 ), Allylpalladium(II) chloride dimer, Pd(allyl)Cl] 2 ) , Palladium on carbon (Pd/C), or palladium (II) chloride (Palladium (II) chloride, PdCl 2 ), and the like, and any one or a mixture of two or more of them may be used.
또, 상기 염기(base)로는 소듐 tert-부톡사이드(sodium tert-butoxide, NaOtBu), 포타슘 tert-부톡사이드(potassium tert-butoxide), 소듐 tert―펜톡사이드(sodium tert-pentoxide), 소듐 에톡사이드(sodium ethoxide), 소듐 카보네이트(sodium carbonate), 포타슘 카보네이트(potassium carbonate), 세슘 카보네이트(cesium carbonate), 소듐 하이드리드(sodium hydride), 리튬 하이드리드(lithium hydride) 또는 포타슘 하이드리드(potassium hydride) 등과 같은 무기 염기; 테트라에틸암모늄 히드록시드((Et4NOH), 비스(테트라에틸암모늄)탄산염, 트리에틸아민 등의 유기 염기; 불화세슘 등의 무기염을 들 수 있으며, 이들 중 어느 하나 또는 둘 이상의 혼합물이 사용될 수 있다. In addition, as the base, sodium tert-butoxide (NaOtBu), potassium tert-butoxide, sodium tert-pentoxide, sodium ethoxide ( sodium ethoxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium hydride, lithium hydride or potassium hydride. inorganic bases; organic bases such as tetraethylammonium hydroxide ((Et 4 NOH), bis(tetraethylammonium)carbonate, and triethylamine; and inorganic salts such as cesium fluoride, any one or a mixture of two or more of these may be used. can
또, 상기 스즈키 커플링 반응은 물, 유기 용매, 또는 이들의 혼합 용매 중에서 수행될 수 있으며, 상기 유기 용매로는, 디에틸 에테르, 테트라히드로푸란, 1,4-디옥산, 에틸렌 글리콜 디에틸 에테르, 디메톡시에탄, 비스(2-메톡시에틸)에테르, 디에틸렌 글리콜 디에틸 에테르, 테트라하이드로퓨란 또는 아니솔과 같은 에테르 용매; 벤젠, 톨루엔 또는 자일렌과 같은 방향족 탄화수소계 용매; 클로로벤젠, 디메틸포름아마이드, 디메틸아세트아마이드, N-메틸피롤리돈, 디메틸이미다졸리돈 또는 아세토니트릴과 같은 할로겐화 방향족 용매; 또는 디메틸술폭사이드(DMSO)와 같은 설폭사이드계 용매 등을 들 수 있으며, 이들 중 어느 하나 또는 둘 이상의 혼합물이 사용될 수 있다.In addition, the Suzuki coupling reaction may be carried out in water, an organic solvent, or a mixed solvent thereof, and the organic solvent includes diethyl ether, tetrahydrofuran, 1,4-dioxane, ethylene glycol diethyl ether ether solvents such as dimethoxyethane, bis(2-methoxyethyl)ether, diethylene glycol diethyl ether, tetrahydrofuran or anisole; aromatic hydrocarbon-based solvents such as benzene, toluene or xylene; halogenated aromatic solvents such as chlorobenzene, dimethylformamide, dimethylacetamide, N-methylpyrrolidone, dimethylimidazolidone or acetonitrile; or a sulfoxide-based solvent such as dimethyl sulfoxide (DMSO), and any one or a mixture of two or more of these may be used.
한편, 상기 화학식 1의 화합물(1) 제조에 사용되는 반응 물질들, 화합물 (i) 및 (ii)는 통상의 유기 반응을 이용하여 제조할 수도 있고, 또는 상업적으로 입수하여 사용할 수도 있다. 상기 제조 방법은 후술할 제조예에서 보다 구체화될 수 있다.Meanwhile, the reactants used in preparing compound (1) of
또한, 본 발명은 상기 화학식 1로 표시되는 화합물을 포함하는 유기 발광 소자를 제공한다. 일례로, 본 발명은 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물 층을 포함하는 유기 발광 소자로서, 상기 유기물 층 중 1층 이상은 상기 화학식 1로 표시되는 화합물을 포함하는, 유기 발광 소자를 제공한다. In addition, the present invention provides an organic light emitting device including the compound represented by
상기 유기 발광 소자에 있어서, 상기 제1 전극은 양극이고, 상기 제2 전극은 음극이거나, 또는 상기 제1 전극은 음극이고, 상기 제2 전극은 양극일 수 있다.In the organic light emitting device, the first electrode may be an anode and the second electrode may be a cathode, or the first electrode may be a cathode and the second electrode may be an anode.
또, 본 발명의 유기 발광 소자의 유기물 층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물 층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 본 발명의 유기 발광 소자는 유기물 층으로서 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 또는 전자 주입 및 수송층 등을 포함하는 구조를 가질 수 있다. 그러나 유기 발광 소자의 구조는 이에 한정되지 않고 더 적은 수의 유기물 층을 포함할 수 있다.Also, the organic material layer of the organic light emitting device of the present invention may have a single-layer structure, or may have a multi-layer structure in which two or more organic material layers are stacked. For example, the organic light emitting device of the present invention may have a structure including a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, or an electron injection and transport layer as organic layers. However, the structure of the organic light emitting diode is not limited thereto and may include a smaller number of organic material layers.
일 구현예에서, 상기 유기물층은 발광층을 포함할 수 있고, 이때 상기 화합물을 포함하는 유기물층은 발광층일 수 있다.In one embodiment, the organic material layer may include a light emitting layer, and in this case, the organic material layer including the compound may be a light emitting layer.
다른 구현예에서, 상기 유기물층은 정공주입층, 정공수송층, 발광층 및 전자주입 및 수송층을 포함할 수 있고, 이때 상기 화합물을 포함하는 유기물층은 발광층일 수 있다.In another embodiment, the organic material layer may include a hole injection layer, a hole transport layer, a light emitting layer, and an electron injection and transport layer, wherein the organic material layer including the compound may be a light emitting layer.
또 다른 구현예에서, 상기 유기물층은 정공주입층, 정공수송층, 전자억제층, 발광층 그리고 전자주입 및 수송층을 포함할 수 있고, 이때 상기 화합물을 포함하는 유기물층은 발광층일 수 있다.In another embodiment, the organic material layer may include a hole injection layer, a hole transport layer, an electron blocking layer, a light emitting layer, and an electron injection and transport layer, wherein the organic material layer including the compound may be a light emitting layer.
또 다른 구현예에서, 상기 유기물층은 정공주입층, 정공수송층, 전자억제층, 발광층, 정공저지층, 그리고 전자주입 및 수송층을 포함할 수 있고, 이때 상기 화합물을 포함하는 유기물층은 발광층일 수 있다.In another embodiment, the organic material layer may include a hole injection layer, a hole transport layer, an electron blocking layer, a light emitting layer, a hole blocking layer, and an electron injection and transport layer, wherein the organic material layer containing the compound may be a light emitting layer.
또한, 본 발명에 따른 유기 발광 소자는, 기판 상에 양극, 1층 이상의 유기물 층 및 음극이 순차적으로 적층된 구조(normal type)의 유기 발광 소자일 수 있다. 또한, 본 발명에 따른 유기 발광 소자는 기판 상에 음극, 1층 이상의 유기물 층 및 양극이 순차적으로 적층된 역방향 구조(inverted type)의 유기 발광 소자일 수 있다. 예컨대, 본 발명의 일 실시예에 따른 유기 발광 소자의 구조는 도 1 및 2에 예시되어 있다.Also, the organic light emitting device according to the present invention may be a normal type organic light emitting device in which an anode, one or more organic material layers, and a cathode are sequentially stacked on a substrate. In addition, the organic light emitting device according to the present invention may be an organic light emitting device of an inverted type in which a cathode, one or more organic material layers, and an anode are sequentially stacked on a substrate. For example, the structure of an organic light emitting device according to an embodiment of the present invention is illustrated in FIGS. 1 and 2 .
도 1은 기판(1), 양극(2), 유기물 층(3) 및 음극(4)으로 이루어진 유기 발광 소자의 예를 도시한 것이다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 유기물 층(3)에 포함될 수 있다.1 shows an example of an organic light emitting device composed of a
도 2는 기판(1), 양극(2), 정공주입층(5), 정공수송층(6), 전자억제층(7), 발광층(8), 정공저지층(9), 전자 주입 및 수송층(10), 및 음극(4)으로 이루어진 유기 발광 소자의 예를 도시한 것이다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 정공주입층(5), 정공수송층(6), 전자억제층(7), 발광층(8), 정공저지층(9) 및 전자 주입 및 수송층(10) 중 1층 이상에 포함될 수 있다. 2 shows a
본 발명에 따른 유기 발광 소자는, 상기 유기물 층 중 1층 이상이 상기 화학식 1로 표시되는 화합물을 포함하는 것을 제외하고는 당 기술분야에 알려져 있는 재료와 방법으로 제조될 수 있다. 또한, 상기 유기 발광 소자가 복수개의 유기물 층을 포함하는 경우, 상기 유기물 층은 동일한 물질 또는 다른 물질로 형성될 수 있다. The organic light emitting device according to the present invention may be manufactured using materials and methods known in the art, except that at least one of the organic layers includes the compound represented by
예컨대, 본 발명에 따른 유기 발광 소자는 기판 상에 양극, 유기물 층 및 음극을 순차적으로 적층시켜 제조할 수 있다. 이때, 스퍼터링법(sputtering)이나 전자빔 증발법(e-beam evaporation)과 같은 PVD(physical Vapor Deposition)방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공주입층, 정공수송층, 전자억제층, 발광층, 정공저지층, 그리고 전자 주입 및 수송층을 포함하는 유기물 층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시켜 제조할 수 있다. For example, the organic light emitting device according to the present invention may be manufactured by sequentially stacking an anode, an organic material layer, and a cathode on a substrate. At this time, by using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation, depositing a metal or a metal oxide having conductivity or an alloy thereof on the substrate to form an anode After forming an organic material layer including a hole injection layer, a hole transport layer, an electron blocking layer, a light emitting layer, a hole blocking layer, and an electron injection and transport layer thereon, and depositing a material that can be used as a cathode thereon, it can be prepared. there is.
또한, 상기 화학식 1로 표시되는 화합물은 유기 발광 소자의 제조시 진공 증착법 뿐만 아니라 용액 도포법에 의하여 유기물 층으로 형성될 수 있다. 여기서, 용액 도포법이라 함은 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅, 스크린 프린팅, 스프레이법, 롤 코팅 등을 의미하지만, 이들만으로 한정되는 것은 아니다.In addition, the compound represented by
이와 같은 방법 외에도, 기판 상에 음극 물질로부터 유기물 층, 양극 물질을 차례로 증착시켜 유기 발광 소자를 제조할 수 있다(WO 2003/012890). 다만, 제조 방법이 이에 한정되는 것은 아니다. In addition to this method, an organic light emitting device may be manufactured by sequentially depositing an organic material layer and an anode material on a substrate from a cathode material (WO 2003/012890). However, the manufacturing method is not limited thereto.
상기 양극 물질로는 통상 유기물 층으로 정공 주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 상기 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연 산화물, 인듐 산화물, 인듐주석 산화물(ITO), 인듐아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDOT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다. As the anode material, a material having a high work function is generally preferred so that holes can be smoothly injected into the organic layer. Specific examples of the cathode material include metals such as vanadium, chromium, copper, zinc, and gold or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO 2 :Sb; Conductive polymers such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDOT), polypyrrole, and polyaniline, but are not limited thereto.
상기 음극 물질로는 통상 유기물 층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 상기 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 티타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다. The cathode material is preferably a material having a small work function so as to facilitate electron injection into the organic material layer. Specific examples of the anode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; There are multi-layered materials such as LiF/Al or LiO 2 /Al, but are not limited thereto.
상기 정공주입층은 전극으로부터 정공을 주입하는 층으로, 정공 주입 물질로는 정공을 수송하는 능력을 가져 양극에서의 정공 주입효과, 발광층 또는 발광재료에 대하여 우수한 정공 주입 효과를 갖고, 발광층에서 생성된 여기자의 전자주입층 또는 전자주입재료에의 이동을 방지하며, 또한, 박막 형성 능력이 우수한 화합물이 바람직하다. 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물 층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrin), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴헥사아자트리페닐렌 계열의 유기물, 퀴나크리돈(quinacridone)계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다. The hole injection layer is a layer for injecting holes from the electrode, and the hole injection material has the ability to transport holes and has a hole injection effect at the anode, an excellent hole injection effect for the light emitting layer or the light emitting material, and generated in the light emitting layer A compound that prevents migration of excitons to the electron injecting layer or electron injecting material and has excellent thin film formation ability is preferred. It is preferable that the highest occupied molecular orbital (HOMO) of the hole injection material is between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injection material include metal porphyrins, oligothiophenes, arylamine-based organic materials, hexanitrilehexaazatriphenylene-based organic materials, quinacridone-based organic materials, and perylene-based organic materials. of organic materials, anthraquinone, polyaniline, and polythiophene-based conductive polymers, but are not limited thereto.
상기 정공수송층은 정공주입층으로부터 정공을 수취하여 발광층까지 정공을 수송하는 층으로, 정공 수송 물질로 양극이나 정공 주입층으로부터 정공을 수송받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다. The hole transport layer is a layer that receives holes from the hole injection layer and transports the holes to the light emitting layer. As a hole transport material, a material capable of receiving holes from the anode or the hole injection layer and transferring them to the light emitting layer is a material having high hole mobility. this is suitable Specific examples include, but are not limited to, arylamine-based organic materials, conductive polymers, and block copolymers having both conjugated and non-conjugated parts.
상기 전자억제층은 상기 정공수송층 상에 형성되어, 바람직하게는 발광층에 접하여 구비되어, 정공이동도를 조절하고, 전자의 과다한 이동을 방지하여 정공-전자간 결합 확률을 높여줌으로써 유기 발광 소자의 효율을 개선하는 역할을 하는 층을 의미한다. 상기 전자억제층은 전자저지물질을 포함하고, 이러한 전자저지물질의 예로 아릴아민 계열의 유기물 등을 사용할 수 있으나, 이에 한정되는 것은 아니다.The electron blocking layer is formed on the hole transport layer, and is preferably provided in contact with the light emitting layer to control hole mobility and prevent excessive movement of electrons to increase hole-electron coupling probability, thereby increasing the efficiency of the organic light emitting device. means a layer that serves to improve The electron blocking layer includes an electron blocking material, and an arylamine-based organic material may be used as an example of the electron blocking material, but is not limited thereto.
상기 발광층은 호스트 재료 및 도펀트 재료를 포함할 수 있다. 호스트 재료로는 상술한 화학식 1로 표시되는 화합물이 사용될 수 있다. 또한, 호스트 재료로는 상기 화학식 1로 표시되는 화합물 이외에 축합 방향족환 유도체 또는 헤테로환 함유 화합물 등을 추가로 사용할 수 있다. 구체적으로 축합 방향족환 유도체로는 안트라센 유도체, 피렌 유도체, 나프탈렌 유도체, 펜타센 유도체, 페난트렌 화합물, 플루오란텐 화합물 등이 있고, 헤테로환 함유 화합물로는 카바졸 유도체, 디벤조퓨란 유도체, 래더형 퓨란 화합물, 피리미딘 유도체 등이 있으나, 이에 한정되지 않는다. The light emitting layer may include a host material and a dopant material. As the host material, the compound represented by
또한, 도펀트 재료로는 방향족 아민 유도체, 스트릴아민 화합물, 붕소 착체, 플루오란텐 화합물, 금속 착체 등이 있다. 구체적으로 방향족 아민 유도체로는 치환 또는 비치환된 아릴아미노기를 갖는 축합 방향족환 유도체로서, 아릴아미노기를 갖는 피렌, 안트라센, 크리센, 페리플란텐 등이 있으며, 스티릴아민 화합물로는 치환 또는 비치환된 아릴아민에 적어도 1개의 아릴비닐기가 치환되어 있는 화합물로, 아릴기, 실릴기, 알킬기, 사이클로알킬기 및 아릴아미노기로 이루어진 군에서 1 또는 2 이상 선택되는 치환기가 치환 또는 비치환된다. 구체적으로 스티릴아민, 스티릴디아민, 스티릴트리아민, 스티릴테트라아민 등이 있으나, 이에 한정되지 않는다. 또한, 금속 착체로는 이리듐 착체, 백금 착체 등이 있으나, 이에 한정되지 않는다.In addition, examples of the dopant material include aromatic amine derivatives, strylamine compounds, boron complexes, fluoranthene compounds, metal complexes, and the like. Specifically, aromatic amine derivatives are condensed aromatic ring derivatives having a substituted or unsubstituted arylamino group, such as pyrene, anthracene, chrysene, periplanthene, etc. having an arylamino group, and styrylamine compounds include substituted or unsubstituted arylamine is substituted with at least one arylvinyl group, wherein one or two or more substituents selected from the group consisting of an aryl group, a silyl group, an alkyl group, a cycloalkyl group, and an arylamino group are substituted or unsubstituted. Specifically, there are styrylamine, styryldiamine, styryltriamine, styryltetraamine, etc., but is not limited thereto. In addition, metal complexes include, but are not limited to, iridium complexes and platinum complexes.
보다 구체적으로 상기 도펀트 재료로는 하기 구조의 화합물들을 들 수 있으나, 이에 한정되지 않는다:More specifically, the dopant material may include compounds having the following structure, but is not limited thereto:
. .
상기 정공저지층은 발광층 상에 형성되어, 바람직하게는 발광층에 접하여 구비되어, 전자이동도를 조절하고 정공의 과다한 이동을 방지하여 정공-전자간 결합 확률을 높여줌으로써 유기 발광 소자의 효율을 개선하는 역할을 하는 층을 의미한다. 상기 정공저지층은 정공저지물질을 포함하고, 이러한 정공저지물질의 예로 트리아진을 포함한 아진류유도체; 트리아졸 유도체; 옥사디아졸 유도체; 페난트롤린 유도체; 포스핀옥사이드 유도체 등의 전자흡인기가 도입된 화합물을 사용할 수 있으나, 이에 한정되는 것은 아니다.The hole blocking layer is formed on the light emitting layer, preferably provided in contact with the light emitting layer, to improve the efficiency of the organic light emitting device by controlling electron mobility and preventing excessive movement of holes to increase the probability of hole-electron coupling layers that play a role. The hole blocking layer includes a hole blocking material, and examples of the hole blocking material include azine derivatives including triazine; triazole derivatives; oxadiazole derivatives; phenanthroline derivatives; A compound having an electron withdrawing group such as a phosphine oxide derivative may be used, but is not limited thereto.
상기 전자 주입 및 수송층은 전극으로부터 전자를 주입하고, 수취된 전자를 발광층까지 수송하는 전자수송층 및 전자주입층의 역할을 동시에 수행하는 층으로, 상기 발광층 또는 상기 정공저지층 상에 형성된다. 이러한 전자 주입 및 수송물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 전자 주입 및 수송물질의 예로는 8-히드록시퀴놀린의 Al 착물; Alq3를 포함한 착물; 유기 라디칼 화합물; 히드록시플라본-금속 착물; 트리아진 유도체 등이 있으나, 이들에만 한정되는 것은 아니다. 또는 플루오레논, 안트라퀴노다이메탄, 다이페노퀴논, 티오피란 다이옥사이드, 옥사졸, 옥사다이아졸, 트리아졸, 이미다졸, 페릴렌테트라카복실산, 프레오레닐리덴 메탄, 안트론 등과 그들의 유도체, 금속 착체 화합물, 또는 질소 함유 5원환 유도체 등과 함께 사용할 수도 있으나, 이에 한정되는 것은 아니다. The electron injection and transport layer is a layer that simultaneously serves as an electron transport layer and an electron injection layer for injecting electrons from an electrode and transporting the received electrons to the light emitting layer, and is formed on the light emitting layer or the hole blocking layer. As such an electron injecting and transporting material, a material capable of receiving electrons from the cathode and transferring them to the light emitting layer is suitable. Examples of specific electron injection and transport materials include Al complexes of 8-hydroxyquinoline; Complexes containing Alq 3 ; organic radical compounds; hydroxyflavone-metal complexes; triazine derivatives, etc., but are not limited thereto. Or fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, fluorenylidene methane, anthrone, etc. and their derivatives, metal complex compounds , or may be used together with nitrogen-containing 5-membered ring derivatives, etc., but is not limited thereto.
상기 금속 착체 화합물로서는 8-하이드록시퀴놀리나토 리튬, 비스(8-하이드록시퀴놀리나토)아연, 비스(8-하이드록시퀴놀리나토)구리, 비스(8-하이드록시퀴놀리나토)망간, 트리스(8-하이드록시퀴놀리나토)알루미늄, 트리스(2-메틸-8-하이드록시퀴놀리나토)알루미늄, 트리스(8-하이드록시퀴놀리나토)갈륨, 비스(10-하이드록시벤조[h]퀴놀리나토)베릴륨, 비스(10-하이드록시벤조[h]퀴놀리나토)아연, 비스(2-메틸-8-퀴놀리나토)클로로갈륨, 비스(2-메틸-8-퀴놀리나토)(o-크레졸라토)갈륨, 비스(2-메틸-8-퀴놀리나토)(1-나프톨라토)알루미늄, 비스(2-메틸-8-퀴놀리나토)(2-나프톨라토)갈륨 등이 있으나, 이에 한정되는 것은 아니다.Examples of the metal complex compound include 8-hydroxyquinolinato lithium, bis(8-hydroxyquinolinato)zinc, bis(8-hydroxyquinolinato)copper, bis(8-hydroxyquinolinato)manganese, Tris(8-hydroxyquinolinato) aluminum, tris(2-methyl-8-hydroxyquinolinato) aluminum, tris(8-hydroxyquinolinato) gallium, bis(10-hydroxybenzo[h] Quinolinato) beryllium, bis(10-hydroxybenzo[h]quinolinato)zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato)( There are o-cresolato) gallium, bis(2-methyl-8-quinolinato)(1-naphtolato)aluminum, and bis(2-methyl-8-quinolinato)(2-naphtolato)gallium. It is not limited to this.
상기 전자 주입 및 수송층은 전자주입층 및 전자수송층과 같은 별개의 층으로도 형성될 수 있다. 이와 같은 경우, 전자 수송층은 상기 발광층 또는 상기 정공저지층 상에 형성되고, 상기 전자 수송층에 포함되는 전자 수송 물질로는 상술한 전자 주입 및 수송 물질이 사용될 수 있다. 또한, 전자 주입층은 상기 전자 수송층 상에 형성되고, 상기 전자 주입층에 포함되는 전자 주입 물질로는 LiF, NaCl, CsF, Li2O, BaO, 플루오레논, 안트라퀴노다이메탄, 다이페노퀴논, 티오피란 다이옥사이드, 옥사졸, 옥사다이아졸, 트리아졸, 이미다졸, 페릴렌테트라카복실산, 플루오레닐리덴 메탄, 안트론 등과 그들의 유도체, 금속 착체 화합물 및 질소 함유 5원환 유도체 등이 사용될 수 있다.The electron injection and transport layer may also be formed as a separate layer such as an electron injection layer and an electron transport layer. In this case, the electron transport layer is formed on the light emitting layer or the hole blocking layer, and the above-described electron injection and transport material may be used as an electron transport material included in the electron transport layer. In addition, the electron injection layer is formed on the electron transport layer, and examples of electron injection materials included in the electron injection layer include LiF, NaCl, CsF, Li 2 O, BaO, fluorenone, anthraquinodimethane, diphenoquinone, Thiophyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylene tetracarboxylic acid, fluorenylidene methane, anthrone, etc. and their derivatives, metal complex compounds, nitrogen-containing 5-membered ring derivatives, and the like can be used.
본 발명에 따른 유기 발광 소자는 배면 발광(bottom emission) 소자, 전면 발광(top emission) 소자, 또는 양면 발광 소자일 수 있으며, 특히 상대적으로 높은 발광 효율이 요구되는 배면 발광 소자일 수 있다.The organic light emitting device according to the present invention may be a bottom emission device, a top emission device, or a double-sided light emitting device, and in particular, may be a bottom emission device requiring relatively high light emitting efficiency.
또한, 상기 화학식 1로 표시되는 화합물은 유기 발광 소자 외에도 유기 태양 전지 또는 유기 트랜지스터에 포함될 수 있다.In addition, the compound represented by
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예들을 제시한다. 다만, 하기의 실시예들은 본 발명을 예시하기 위한 것일 뿐, 본 발명의 내용이 하기 실시예들에 의하여 한정되는 것은 아니다Hereinafter, preferred embodiments are presented to aid understanding of the present invention. However, the following examples are only for illustrating the present invention, and the content of the present invention is not limited by the following examples.
제조예 1Preparation Example 1
화합물 AA의 제조Preparation of Compound AA
질소 분위기에서 sub1 (10g, 27.5mmol)와 sub2 (4.2g, 28.1mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(11.4g, 82.6mmol)를 물 34ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.3mmol)을 투입하였다. 8시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 AA_P1를 6.9g 제조하였다. (수율 74%, MS: [M+H]+= 341)In a nitrogen atmosphere, sub1 (10g, 27.5mmol) and sub2 (4.2g, 28.1mmol) were added to 200ml of THF and stirred and refluxed. Thereafter, potassium carbonate (11.4g, 82.6mmol) was dissolved in 34ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.3mmol) was added. After reacting for 8 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.9 g of AA_P1. (Yield 74%, MS: [M+H]+= 341)
질소 분위기에서 AA_P1 (10g, 29.3mmol)를 AcOH 200ml에 넣고 교반 및 0oC까지 냉각하였다. 이 후 Hydrazine monohydrate (1.6g, 32.2mmol)를 천천히 투입 한 후, 교반 및 환류하였다. 12시간 반응 후 상온으로 식히고 유기용매를 감압 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 AA_P2를 7.1g 제조하였다. (수율 79%, MS: [M+H]+= 309)In a nitrogen atmosphere, AA_P1 (10 g, 29.3 mmol) was added to 200 ml of AcOH, stirred and cooled to 0 ° C. After this, Hydrazine monohydrate (1.6g, 32.2mmol) was slowly added, followed by stirring and refluxing. After reacting for 12 hours, the mixture was cooled to room temperature and the organic solvent was distilled under reduced pressure. This was again dissolved in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.1 g of AA_P2. (Yield 79%, MS: [M+H]+= 309)
질소 분위기에서 AA_P2 (10g, 32.3mmol)와 sub3 (6.7g, 35.5mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(13.4g, 96.9mmol)를 물 40ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 9시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 AA_P3를 9.6g 제조하였다. (수율 80%, MS: [M+H]+= 373)AA_P2 (10g, 32.3mmol) and sub3 (6.7g, 35.5mmol) were added to 200ml of THF under a nitrogen atmosphere and stirred and refluxed. Thereafter, potassium carbonate (13.4g, 96.9mmol) was dissolved in 40ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 9 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.6 g of AA_P3. (Yield 80%, MS: [M+H]+= 373)
질소 분위기에서 AA_P3 (10g, 26.8mmol)와 potassium carbonate(11.1g, 80.5mmol)를 DMAc 200ml에 넣고 교반 및 환류하였다. 9시간 반응 후 상온으로 식히고 유기용매를 감압 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 AA_P4를 5.8g 제조하였다. (수율 61%, MS: [M+H]+= 353)AA_P3 (10g, 26.8mmol) and potassium carbonate (11.1g, 80.5mmol) were added to 200ml of DMAc under a nitrogen atmosphere, followed by stirring and refluxing. After reacting for 9 hours, the mixture was cooled to room temperature and the organic solvent was distilled under reduced pressure. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 5.8 g of AA_P4. (Yield 61%, MS: [M+H]+= 353)
질소 분위기에서 AA_P4 (15g, 42.5mmol)와 bis(pinacolato)diboron (11.9g, 46.8mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (12.5g, 127.5mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (0.7g, 1.3mmol) 및 tricyclohexylphosphine (0.7g, 2.6mmol)을 투입하였다. 5시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 AA를 14.4g 제조하였다. (수율 76%, MS: [M+H]+= 445)AA_P4 (15g, 42.5mmol) and bis(pinacolato)diboron (11.9g, 46.8mmol) were refluxed and stirred in 300ml of 1,4-dioxane in a nitrogen atmosphere. Then, potassium acetate (12.5g, 127.5mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (0.7g, 1.3mmol) and tricyclohexylphosphine (0.7g, 2.6mmol) were added. After reacting for 5 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.4 g of Compound AA. (Yield 76%, MS: [M+H]+= 445)
제조예 2Preparation Example 2
화학식 AB의 제조Preparation of Formula AB
상기 제조예 1에서 출발 물질로 sub1 대신 sub4를 사용한 것을 제외하고는, 제조예 1과 동일한 방법을 사용하여 화합물 AB를 11.8g 제조하였다. (수율 80%, MS: [M+H]+= 445)11.8 g of Compound AB was prepared in the same manner as in Preparation Example 1, except that sub4 was used instead of sub1 as a starting material in Preparation Example 1. (Yield 80%, MS: [M+H]+= 445)
제조예 3Preparation Example 3
화합물 AC의 제조Preparation of compound AC
질소 분위기에서 sub5 (10g, 30.4mmol)와 sub2 (5g, 33.4mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.6g, 91.2mmol)를 물 38ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 8시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 AC_P1를 6g 제조하였다. (수율 65%, MS: [M+H]+= 307)In a nitrogen atmosphere, sub5 (10g, 30.4mmol) and sub2 (5g, 33.4mmol) were added to 200ml of THF and stirred and refluxed. Thereafter, potassium carbonate (12.6g, 91.2mmol) was dissolved in 38ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 8 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6 g of AC_P1. (Yield 65%, MS: [M+H]+= 307)
질소 분위기에서 AC_P1 (10g, 32.6mmol)를 AcOH 200ml에 넣고 교반 및 0oC까지 냉각하였다. 이 후 Hydrazine monohydrate (1.8g, 35.8mmol)를 천천히 투입 한 후, 교반 및 환류하였다. 12시간 반응 후 상온으로 식히고 유기용매를 감압 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 AC_P2를 6.4g 제조하였다. (수율 72%, MS: [M+H]+= 275)In a nitrogen atmosphere, AC_P1 (10 g, 32.6 mmol) was added to 200 ml of AcOH, stirred and cooled to 0 ° C. Afterwards, Hydrazine monohydrate (1.8g, 35.8mmol) was slowly added, followed by stirring and refluxing. After reacting for 12 hours, the mixture was cooled to room temperature and the organic solvent was distilled under reduced pressure. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.4 g of AC_P2. (Yield 72%, MS: [M+H]+= 275)
질소 분위기에서 AC_P2 (20g, 77.8mmol), N-Chlorosuccinimide (10.6g, 79.3mmol)을 chloroform 400ml에 넣고 상온에서 교반하였다. 6시간 반응 후, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 AC_P3를 6.7g 제조하였다. (수율 28%, MS: [M+H]+= 309)AC_P2 (20g, 77.8mmol) and N-Chlorosuccinimide (10.6g, 79.3mmol) were added to 400ml of chloroform in a nitrogen atmosphere and stirred at room temperature. After reacting for 6 hours, the organic layer was separated after washing twice with water, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.7 g of AC_P3. (Yield 28%, MS: [M+H]+= 309)
질소 분위기에서 AA_P3 (10g, 32.3mmol)와 sub3 (6.7g, 35.5mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(13.4g, 96.9mmol)를 물 40ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 AC_P4를 7.8g 제조하였다. (수율 65%, MS: [M+H]+= 373)AA_P3 (10g, 32.3mmol) and sub3 (6.7g, 35.5mmol) were added to 200ml of THF under a nitrogen atmosphere and stirred and refluxed. Thereafter, potassium carbonate (13.4g, 96.9mmol) was dissolved in 40ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was again dissolved in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.8 g of AC_P4. (Yield 65%, MS: [M+H]+= 373)
질소 분위기에서 AC_P4 (10g, 26.8mmol)와 potassium carbonate(11.1g, 80.5mmol)를 DMAc 200ml에 넣고 교반 및 환류하였다. 9시간 반응 후 상온으로 식히고 유기용매를 감압 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 AC_P5를 5.9g 제조하였다. (수율 63%, MS: [M+H]+= 353)In a nitrogen atmosphere, AC_P4 (10g, 26.8mmol) and potassium carbonate (11.1g, 80.5mmol) were added to 200ml of DMAc and stirred and refluxed. After reacting for 9 hours, the mixture was cooled to room temperature and the organic solvent was distilled under reduced pressure. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 5.9 g of AC_P5. (Yield 63%, MS: [M+H]+= 353)
질소 분위기에서 AC_P5 (15g, 42.5mmol)와 bis(pinacolato)diboron (11.9g, 46.8mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (12.5g, 127.5mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (0.7g, 1.3mmol) 및 tricyclohexylphosphine (0.7g, 2.6mmol)을 투입하였다. 5시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 AC를 13g 제조하였다. (수율 69%, MS: [M+H]+= 445)AC_P5 (15g, 42.5mmol) and bis(pinacolato)diboron (11.9g, 46.8mmol) were refluxed and stirred in 300ml of 1,4-dioxane in a nitrogen atmosphere. Then, potassium acetate (12.5g, 127.5mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (0.7g, 1.3mmol) and tricyclohexylphosphine (0.7g, 2.6mmol) were added. After reacting for 5 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13 g of Compound AC. (Yield 69%, MS: [M+H]+= 445)
제조예 4Production Example 4
화합물 AD의 제조Preparation of compound AD
상기 제조예 3에서 AC_P2로부터 AC_P3의 제조시 AC_P3과 함께 생성되는 AD_P1을 실리카 겔 컬럼 크로마토그래피로 정제 분리하여 사용하며, 이를 sub 3과 반응시키는 것을 제외하고는, 상기 제조예 3과 동일한 방법으로 수행하여 화합물 AD를 11.9g 제조하였다. (수율 63%, MS: [M+H]+= 445)When AC_P3 was prepared from AC_P2 in Preparation Example 3, AD_P1 produced together with AC_P3 was purified and separated by silica gel column chromatography, and the same method as in Preparation Example 3 was performed, except that it was reacted with
제조예 5Preparation Example 5
화합물 AE의 제조Preparation of compound AE
상기 제조예 1에서 출발 물질로 sub1 대신 sub5를 사용하고, sub2 대신 sub6를 사용한 것을 제외하고는, 제조예 1과 동일한 방법을 사용하여 화합물 AE를 15.1g 제조하였다. (수율 80%, MS: [M+H]+= 445)15.1 g of Compound AE was prepared in the same manner as in Preparation Example 1, except that sub5 was used instead of sub1 and sub6 was used instead of sub2 as the starting material in Preparation Example 1. (Yield 80%, MS: [M+H]+= 445)
제조예 6Preparation Example 6
화합물 AF의 제조Preparation of Compound AF
상기 제조예 1에서 출발 물질로 sub1 대신 sub5를 사용하고, sub2 대신 sub7를 사용한 것을 제외하고는, 제조예 1과 동일한 방법을 사용하여 화합물 AF를 12.1g 제조하였다. (수율 64%, MS: [M+H]+= 445)12.1 g of Compound AF was prepared in the same manner as in Preparation Example 1, except that sub5 was used instead of sub1 and sub7 was used instead of sub2 as the starting material in Preparation Example 1. (Yield 64%, MS: [M+H]+= 445)
제조예 7Preparation Example 7
화합물 AG의 제조Preparation of compound AG
상기 제조예 1에서 출발 물질로 sub1 대신 sub5를 사용하고, sub2 대신 sub8를 사용한 것을 제외하고는, 제조예 1과 동일한 방법을 사용하여 화합물 AG를 14.7g 제조하였다. (수율 78%, MS: [M+H]+= 445)14.7 g of Compound AG was prepared in the same manner as in Preparation Example 1, except that sub5 was used instead of sub1 and sub8 was used instead of sub2 as the starting material in Preparation Example 1. (Yield 78%, MS: [M+H]+= 445)
제조예 8Preparation Example 8
화합물 BA의 제조Preparation of compound BA
질소 분위기에서 AA_P2 (10g, 32.3mmol)와 sub9 (6.7g, 35.5mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(13.4g, 96.9mmol)를 물 40ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 9시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 BA_P1를 7.9g 제조하였다. (수율 66%, MS: [M+H]+= 373)AA_P2 (10g, 32.3mmol) and sub9 (6.7g, 35.5mmol) were added to 200ml of THF under a nitrogen atmosphere and stirred and refluxed. Thereafter, potassium carbonate (13.4g, 96.9mmol) was dissolved in 40ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 9 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was again dissolved in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.9 g of BA_P1. (Yield 66%, MS: [M+H]+= 373)
질소 분위기에서 BA_P1 (10g, 26.8mmol)와 potassium carbonate(11.1g, 80.5mmol)를 DMAc 200ml에 넣고 교반 및 환류하였다. 9시간 반응 후 상온으로 식히고 유기용매를 감압 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 BA_P2를 6.6g 제조하였다. (수율 70%, MS: [M+H]+= 353)In a nitrogen atmosphere, BA_P1 (10g, 26.8mmol) and potassium carbonate (11.1g, 80.5mmol) were added to 200ml of DMAc and stirred and refluxed. After reacting for 9 hours, the mixture was cooled to room temperature and the organic solvent was distilled under reduced pressure. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.6 g of BA_P2. (Yield 70%, MS: [M+H]+= 353)
질소 분위기에서 BA_P2 (15g, 42.5mmol)와 bis(pinacolato)diboron (11.9g, 46.8mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (12.5g, 127.5mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (0.7g, 1.3mmol) 및 tricyclohexylphosphine (0.7g, 2.6mmol)을 투입하였다. 5시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 AA를 14.7g 제조하였다. (수율 78%, MS: [M+H]+= 445)BA_P2 (15g, 42.5mmol) and bis(pinacolato)diboron (11.9g, 46.8mmol) were refluxed and stirred in 300ml of 1,4-dioxane in a nitrogen atmosphere. Then, potassium acetate (12.5g, 127.5mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (0.7g, 1.3mmol) and tricyclohexylphosphine (0.7g, 2.6mmol) were added. After reacting for 5 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was again dissolved in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.7 g of Compound AA. (Yield 78%, MS: [M+H]+= 445)
제조예 9Preparation Example 9
화합물 BB의 제조Preparation of Compound BB
상기 제조예 9에서 출발 물질로 AA_P2 대신 AB_P2를 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 BB를 11.8g 제조하였다. (수율 80%, MS: [M+H]+= 445)11.8 g of compound BB was prepared in the same manner as in Preparation Example 9, except that AB_P2 was used instead of AA_P2 as a starting material in Preparation Example 9. (Yield 80%, MS: [M+H]+= 445)
제조예 10Preparation Example 10
화합물 BC 제조compound BC manufacturing
상기 제조예 9에서 출발 물질로 AA_P2 대신 AC_P3를 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 BC를 13g 제조하였다. (수율 69%, MS: [M+H]+= 445)13 g of compound BC was prepared in the same manner as in Preparation Example 9, except that AC_P3 was used instead of AA_P2 as a starting material in Preparation Example 9. (Yield 69%, MS: [M+H]+= 445)
제조예 11Preparation Example 11
화합물 BD 제조compound BD manufacturing
상기 제조예 9에서 출발 물질로 AA_P2 대신 AD_P1를 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 BD를 14.5g 제조하였다. (수율 77%, MS: [M+H]+= 445)14.5 g of compound BD was prepared in the same manner as in Preparation Example 9, except that AD_P1 was used instead of AA_P2 as a starting material in Preparation Example 9. (Yield 77%, MS: [M+H]+= 445)
제조예 12Preparation Example 12
화합물 BE 제조compound BE manufacturing
상기 제조예 9에서 출발 물질로 AA_P2 대신 AE_P2를 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 BE를 11.7g 제조하였다. (수율 62%, MS: [M+H]+= 445)11.7 g of compound BE was prepared in the same manner as in Preparation Example 9, except that AE_P2 was used instead of AA_P2 as a starting material in Preparation Example 9. (Yield 62%, MS: [M+H]+= 445)
제조예 13Preparation Example 13
화합물 BF 제조Preparation of compound BF
상기 제조예 9에서 출발 물질로 AA_P2 대신 AF_P2를 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 BF를 13.6g 제조하였다. (수율 72%, MS: [M+H]+= 445)13.6 g of compound BF was prepared in the same manner as in Preparation Example 9, except that AF_P2 was used instead of AA_P2 as a starting material in Preparation Example 9. (Yield 72%, MS: [M+H]+= 445)
제조예 14Preparation Example 14
화합물 BG 제조compound BG manufacturing
상기 제조예 9에서 출발 물질로 AA_P2 대신 AG_P2를 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 BG를 14.2g 제조하였다. (수율 75%, MS: [M+H]+= 445)14.2 g of compound BG was prepared in the same manner as in Preparation Example 9, except that AG_P2 was used instead of AA_P2 as a starting material in Preparation Example 9. (Yield 75%, MS: [M+H]+= 445)
제조예 15Preparation Example 15
화합물 CA 제조compound CA preparation
상기 제조예 9에서 출발 물질로 sub9 대신 sub10을 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 CA를 11.3g 제조하였다. (수율 60%, MS: [M+H]+= 445)11.3 g of compound CA was prepared in the same manner as in Preparation Example 9, except that sub10 was used instead of sub9 as a starting material in Preparation Example 9. (Yield 60%, MS: [M+H]+= 445)
제조예 16Preparation Example 16
화합물 CB 제조compound CB manufacturing
상기 제조예 9에서 출발 물질로 AA_P2 대신 AB_P2를 사용하고, sub9 대신 sub10을 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 CB를 12.1g 제조하였다. (수율 64%, MS: [M+H]+= 445)12.1 g of compound CB was prepared in the same manner as in Preparation Example 9, except that AB_P2 was used instead of AA_P2 and sub10 was used instead of sub9 in Preparation Example 9. (Yield 64%, MS: [M+H]+= 445)
제조예 17Preparation Example 17
화합물 CC 제조compound CC manufacturing
상기 제조예 9에서 출발 물질로 AA_P2 대신 AC_P3를 사용하고, sub9 대신 sub10을 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 CC를 11.3g 제조하였다. (수율 60%, MS: [M+H]+= 445)11.3 g of compound CC was prepared in the same manner as in Preparation Example 9, except that AC_P3 was used instead of AA_P2 as a starting material and sub10 was used instead of sub9 in Preparation Example 9. (Yield 60%, MS: [M+H]+= 445)
제조예 18Preparation Example 18
화합물 CD 제조compound CD manufacturing
상기 제조예 9에서 출발 물질로 AA_P2 대신 AD_P1를 사용하고, sub9 대신 sub10을 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 CD를 14.4g 제조하였다. (수율 76%, MS: [M+H]+= 445)14.4 g of compound CD was prepared in the same manner as in Preparation Example 9, except that AD_P1 was used instead of AA_P2 and sub10 was used instead of sub9 in Preparation Example 9. (Yield 76%, MS: [M+H]+= 445)
제조예 19Preparation Example 19
화합물 CE 제조compound CE manufacturing
상기 제조예 9에서 출발 물질로 AA_P2 대신 AE_P2를 사용하고, sub9 대신 sub10을 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 CE를 14.7g 제조하였다. (수율 78%, MS: [M+H]+= 445)14.7 g of compound CE was prepared in the same manner as in Preparation Example 9, except that AE_P2 was used instead of AA_P2 and sub10 was used instead of sub9 in Preparation Example 9. (Yield 78%, MS: [M+H]+= 445)
제조예 20Production Example 20
화합물 CF 제조compound CF manufacturing
상기 제조예 9에서 출발 물질로 AA_P2 대신 AF_P2를 사용하고, sub9 대신 sub10을 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 CF를 14.4g 제조하였다. (수율 76%, MS: [M+H]+= 445)14.4 g of compound CF was prepared in the same manner as in Preparation Example 9, except that AF_P2 was used instead of AA_P2 as a starting material and sub10 was used instead of sub9 in Preparation Example 9. (Yield 76%, MS: [M+H]+= 445)
제조예 21Production Example 21
화합물 CG 제조Compound CG Manufacturing
상기 제조예 9에서 출발 물질로 AA_P2 대신 AG_P2를 사용하고, sub9 대신 sub10을 사용한 것을 제외하고는, 제조예 9와 동일한 방법을 사용하여 화합물 CG를 14g 제조하였다. (수율 74%, MS: [M+H]+= 445)14g of compound CG was prepared in the same manner as in Preparation Example 9, except that AG_P2 was used instead of AA_P2 and sub10 was used instead of sub9 in Preparation Example 9. (Yield 74%, MS: [M+H]+= 445)
제조예 22Production Example 22
화합물 DA 제조compound DA preparation
질소 분위기에서 sub11 (10g, 29mmol)와 sub2 (4.8g, 31.9mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12g, 86.9mmol)를 물 36ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.3mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DA_P1를 6g 제조하였다. (수율 64%, MS: [M+H]+= 323)In a nitrogen atmosphere, sub11 (10 g, 29 mmol) and sub2 (4.8 g, 31.9 mmol) were added to 200 ml of THF and stirred and refluxed. Thereafter, potassium carbonate (12g, 86.9mmol) was dissolved in 36ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.3mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6 g of DA_P1. (Yield 64%, MS: [M+H]+= 323)
질소 분위기에서 DA_P1 (10g, 31.1mmol)를 AcOH 200ml에 넣고 교반 및 0oC까지 냉각하였다. 이 후 Hydrazine monohydrate (1.7g, 34.2mmol)를 천천히 투입 한 후, 교반 및 환류하였다. 12시간 반응 후 상온으로 식히고 유기용매를 감압 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DA_P2를 7.1g 제조하였다. (수율 79%, MS: [M+H]+= 291)In a nitrogen atmosphere, DA_P1 (10 g, 31.1 mmol) was added to 200 ml of AcOH, stirred and cooled to 0 ° C. Afterwards, Hydrazine monohydrate (1.7g, 34.2mmol) was slowly added, followed by stirring and refluxing. After reacting for 12 hours, the mixture was cooled to room temperature and the organic solvent was distilled under reduced pressure. This was again dissolved in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.1 g of DA_P2. (Yield 79%, MS: [M+H]+= 291)
질소 분위기에서 DA_P2 (10g, 34.3mmol)와 sub12 (8.2g, 37.7mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.2g, 102.9mmol)를 물 43ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DA_P3를 8.4g 제조하였다. (수율 64%, MS: [M+H]+= 385)DA_P2 (10g, 34.3mmol) and sub12 (8.2g, 37.7mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (14.2g, 102.9mmol) was dissolved in 43ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.4 g of DA_P3. (Yield 64%, MS: [M+H]+= 385)
질소 분위기에서 DA_P3 (10g, 26mmol)와 Hydrogen Peroxide (1.8g, 52mmol)를 아세트산 500ml에 넣고 교반 및 환류하였다. 3시간 후 반응물을 물에 부어서 결정을 떨어트리고 여과했다. 여과한 고체를 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DA_P4를 8.3g 제조하였다. (수율 80%, MS: [M+H]+= 401)DA_P3 (10g, 26mmol) and Hydrogen Peroxide (1.8g, 52mmol) were added to 500ml of acetic acid in a nitrogen atmosphere and stirred and refluxed. After 3 hours, the reaction mixture was poured into water to drop crystals and filtered. The filtered solid was dissolved in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.3 g of DA_P4. (Yield 80%, MS: [M+H]+= 401)
질소 분위기에서 DA_P4 (10g, 24.9mmol)를 H2SO4 200ml에 넣고 교반했다. 2 시간 후 반응이 종료되면 반응물을 물에 부어서 결정을 떨어트리고 여과 했다. 여과한 고체를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DA_P5를 7.1g 제조하였다. (수율 77%, MS: [M+H]+= 369)DA_P4 (10g, 24.9mmol) was added to 200ml of H 2 SO 4 in a nitrogen atmosphere and stirred. When the reaction was completed after 2 hours, the reactant was poured into water to drop crystals and filtered. The filtered solid was dissolved again in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.1 g of DA_P5. (Yield 77%, MS: [M+H]+= 369)
질소 분위기에서 DA_P5 (15g, 40.7mmol)와 bis(pinacolato)diboron (11.4g, 44.7mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (12g, 122mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (0.7g, 1.2mmol) 및 tricyclohexylphosphine (0.7g, 2.4mmol)을 투입하였다. 5시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 DA를 12g 제조하였다. (수율 64%, MS: [M+H]+= 461)DA_P5 (15g, 40.7mmol) and bis(pinacolato)diboron (11.4g, 44.7mmol) were refluxed and stirred in 300ml of 1,4-dioxane in a nitrogen atmosphere. After that, potassium acetate (12g, 122mmol) was added and sufficiently stirred, and then bis(dibenzylideneacetone)palladium(0) (0.7g, 1.2mmol) and tricyclohexylphosphine (0.7g, 2.4mmol) were added. After reacting for 5 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12 g of compound DA. (Yield 64%, MS: [M+H]+= 461)
제조예 23Production Example 23
화합물 DB 제조Compound DB manufacturing
상기 제조예 22에서 출발 물질로 sub11 대신 sub13을 사용한 것을 제외하고는, 제조예 22와 동일한 방법을 사용하여 화합물 DB를 11.8g 제조하였다. (수율 63%, MS: [M+H]+= 461)11.8g of Compound DB was prepared in the same manner as in Preparation Example 22, except that sub13 was used instead of sub11 as a starting material in Preparation Example 22. (Yield 63%, MS: [M+H]+= 461)
제조예 24Production Example 24
화합물 DC 제조Compound DC Preparation
질소 분위기에서 sub14 (10g, 32.2mmol)와 sub2 (5.8g, 38.6mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(13.3g, 96.5mmol)를 물 40ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DC_P1를 5.6g 제조하였다. (수율 60%, MS: [M+H]+= 289)In a nitrogen atmosphere, sub14 (10 g, 32.2 mmol) and sub2 (5.8 g, 38.6 mmol) were added to 200 ml of THF and stirred and refluxed. After that, potassium carbonate (13.3g, 96.5mmol) was dissolved in 40ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 5.6 g of DC_P1. (Yield 60%, MS: [M+H]+= 289)
질소 분위기에서 DC_P1 (10g, 34.6mmol)를 AcOH 200ml에 넣고 교반 및 0oC까지 냉각하였다. 이 후 Hydrazine monohydrate (2.1g, 41.5mmol)를 천천히 투입 한 후, 교반 및 환류하였다. 12시간 반응 후 상온으로 식히고 유기용매를 감압 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DC_P2를 6.6g 제조하였다. (수율 74%, MS: [M+H]+= 257)In a nitrogen atmosphere, DC_P1 (10 g, 34.6 mmol) was added to 200 ml of AcOH, stirred and cooled to 0 ° C. Afterwards, Hydrazine monohydrate (2.1g, 41.5mmol) was slowly added, followed by stirring and refluxing. After reacting for 12 hours, the mixture was cooled to room temperature and the organic solvent was distilled under reduced pressure. This was again dissolved in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.6 g of DC_P2. (Yield 74%, MS: [M+H]+= 257)
질소 분위기에서 DC_P2 (20g, 77.8mmol), N-Chlorosuccinimide (10.6g, 79.3mmol)을 chloroform 400ml에 넣고 상온에서 교반하였다. 6시간 반응 후, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DC_P3를 6.4g 제조하였다. (수율 28%, MS: [M+H]+= 293)DC_P2 (20g, 77.8mmol) and N-Chlorosuccinimide (10.6g, 79.3mmol) were added to 400ml of chloroform in a nitrogen atmosphere and stirred at room temperature. After reacting for 6 hours, the organic layer was separated after washing twice with water, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.4 g of DC_P3. (Yield 28%, MS: [M+H]+= 293)
질소 분위기에서 DA_P3 (10g, 34.3mmol)와 sub12 (9g, 41.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.2g, 102.9mmol)를 물 43ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DA_P4를 9.6g 제조하였다. (수율 73%, MS: [M+H]+= 385)DA_P3 (10g, 34.3mmol) and sub12 (9g, 41.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (14.2g, 102.9mmol) was dissolved in 43ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.6 g of DA_P4. (Yield 73%, MS: [M+H]+= 385)
질소 분위기에서 DC_P4 (10g, 26mmol)와 Hydrogen Peroxide (1.8g, 52mmol)를 아세트산 500ml에 넣고 교반 및 환류하였다. 3시간 후 반응물을 물에 부어서 결정을 떨어트리고 여과했다. 여과한 고체를 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DC_P5를 6.3g 제조하였다. (수율 61%, MS: [M+H]+= 401)DC_P4 (10g, 26mmol) and Hydrogen Peroxide (1.8g, 52mmol) were added to 500ml of acetic acid in a nitrogen atmosphere and stirred and refluxed. After 3 hours, the reaction mixture was poured into water to drop crystals and filtered. The filtered solid was dissolved in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.3 g of DC_P5. (Yield 61%, MS: [M+H]+= 401)
질소 분위기에서 DC_P5 (10g, 24.9mmol)를 H2SO4 200ml에 넣고 교반했다. 2 시간 후 반응이 종료되면 반응물을 물에 부어서 결정을 떨어트리고 여과 했다. 여과한 고체를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 DA_P6를 7.3g 제조하였다. (수율 79%, MS: [M+H]+= 369)In a nitrogen atmosphere, DC_P5 (10g, 24.9mmol) was added to 200ml of H 2 SO 4 and stirred. When the reaction was completed after 2 hours, the reactant was poured into water to drop crystals and filtered. The filtered solid was dissolved again in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.3 g of DA_P6. (Yield 79%, MS: [M+H]+= 369)
질소 분위기에서 DC_P6 (15g, 40.7mmol)와 bis(pinacolato)diboron (11.4g, 44.7mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (12g, 122mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (0.7g, 1.2mmol) 및 tricyclohexylphosphine (0.7g, 2.4mmol)을 투입하였다. 5시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 DC를 12.4g 제조하였다. (수율 66%, MS: [M+H]+= 461)DC_P6 (15g, 40.7mmol) and bis(pinacolato)diboron (11.4g, 44.7mmol) were refluxed and stirred in 300ml of 1,4-dioxane in a nitrogen atmosphere. After that, potassium acetate (12g, 122mmol) was added and sufficiently stirred, and then bis(dibenzylideneacetone)palladium(0) (0.7g, 1.2mmol) and tricyclohexylphosphine (0.7g, 2.4mmol) were added. After reacting for 5 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.4 g of compound DC. (Yield 66%, MS: [M+H]+= 461)
제조예 25Preparation Example 25
화합물 DD의 제조Preparation of compound DD
상기 제조예 24와 동일한 출발 물질로 사용하되, DD_P1 화합물 합성 시, 상기 제조예 24의 DC_P3와 DD_P1이 동시에 생성되며 이를 실리카 겔 컬럼 크로마토그래피로 정제하였다. 이 것을 제외하고는 제조예 24와 동일한 방법을 사용하여 화합물 DD를 12.2g 제조하였다. (수율 65%, MS: [M+H]+= 461)The same starting material as in Preparation Example 24 was used, but when the DD_P1 compound was synthesized, DC_P3 and DD_P1 of Preparation Example 24 were simultaneously produced and purified by silica gel column chromatography. Except for this, 12.2 g of compound DD was prepared using the same method as in Preparation Example 24. (Yield 65%, MS: [M+H]+= 461)
제조예 26Production Example 26
화합물 DE의 제조Preparation of compound DE
상기 제조예 22에서 출발 물질로 sub11 대신 sub14를 사용하고, sub2 대신 sub6를 사용한 것을 제외하고는, 제조예 22와 동일한 방법을 사용하여 화합물 DE를 11.8g 제조하였다. (수율 63%, MS: [M+H]+= 461)11.8 g of compound DE was prepared in the same manner as in Preparation Example 22, except that sub14 was used instead of sub11 and sub6 was used instead of sub2 as the starting material in Preparation Example 22. (Yield 63%, MS: [M+H]+= 461)
제조예 27Production Example 27
화합물 DF의 제조Preparation of compound DF
상기 제조예 22에서 출발 물질로 sub11 대신 sub14를 사용하고, sub2 대신 sub7를 사용한 것을 제외하고는, 제조예 22와 동일한 방법을 사용하여 화합물 DF를 11.8g 제조하였다. (수율 63%, MS: [M+H]+= 461)11.8 g of compound DF was prepared in the same manner as in Preparation Example 22, except that sub14 was used instead of sub11 and sub7 was used instead of sub2 as the starting material in Preparation Example 22. (Yield 63%, MS: [M+H]+= 461)
제조예 28Production Example 28
화합물 DG의 제조Preparation of compound DG
상기 제조예 22에서 출발 물질로 sub11 대신 sub14를 사용하고, sub2 대신 sub8를 사용한 것을 제외하고는, 제조예 22와 동일한 방법을 사용하여 화합물 DG를 13.7g 제조하였다. (수율 73%, MS: [M+H]+= 461)13.7 g of compound DG was prepared in the same manner as in Preparation Example 22, except that sub14 was used instead of sub11 and sub8 was used instead of sub2 in Preparation Example 22. (Yield 73%, MS: [M+H]+= 461)
제조예 29Production Example 29
화합물 EA의 제조Preparation of compound EA
질소 분위기에서 DA_P2 (10g, 34.3mmol)와 sub15 (8.2g, 37.7mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.2g, 102.9mmol)를 물 43ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 EA_P1를 8.4g 제조하였다. (수율 64%, MS: [M+H]+= 385)DA_P2 (10g, 34.3mmol) and sub15 (8.2g, 37.7mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (14.2g, 102.9mmol) was dissolved in 43ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.4 g of EA_P1. (Yield 64%, MS: [M+H]+= 385)
질소 분위기에서 EA_P1 (10g, 26mmol)와 Hydrogen Peroxide (1.8g, 52mmol)를 아세트산 500ml에 넣고 교반 및 환류하였다. 3시간 후 반응물을 물에 부어서 결정을 떨어트리고 여과했다. 여과한 고체를 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 EA_P2를 8.3g 제조하였다. (수율 80%, MS: [M+H]+= 401)EA_P1 (10g, 26mmol) and Hydrogen Peroxide (1.8g, 52mmol) were added to 500ml of acetic acid in a nitrogen atmosphere, followed by stirring and refluxing. After 3 hours, the reaction mixture was poured into water to drop crystals and filtered. The filtered solid was dissolved in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.3 g of EA_P2. (Yield 80%, MS: [M+H]+= 401)
질소 분위기에서 EA_P2 (10g, 24.9mmol)를 H2SO4 200ml에 넣고 교반했다. 2 시간 후 반응이 종료되면 반응물을 물에 부어서 결정을 떨어트리고 여과 했다. 여과한 고체를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 EA_P3를 7.1g 제조하였다. (수율 77%, MS: [M+H]+= 369)EA_P2 (10g, 24.9mmol) was added to 200ml of H 2 SO 4 in a nitrogen atmosphere and stirred. When the reaction was completed after 2 hours, the reactant was poured into water to drop crystals and filtered. The filtered solid was dissolved again in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.1 g of EA_P3. (Yield 77%, MS: [M+H]+= 369)
질소 분위기에서 EA_P3 (15g, 40.7mmol)와 bis(pinacolato)diboron (11.4g, 44.7mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (12g, 122mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (0.7g, 1.2mmol) 및 tricyclohexylphosphine (0.7g, 2.4mmol)을 투입하였다. 5시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 EA를 14.6g 제조하였다. (수율 78%, MS: [M+H]+= 461)EA_P3 (15g, 40.7mmol) and bis(pinacolato)diboron (11.4g, 44.7mmol) were refluxed and stirred in 300ml of 1,4-dioxane in a nitrogen atmosphere. After that, potassium acetate (12g, 122mmol) was added and sufficiently stirred, and then bis(dibenzylideneacetone)palladium(0) (0.7g, 1.2mmol) and tricyclohexylphosphine (0.7g, 2.4mmol) were added. After reacting for 5 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.6 g of compound EA. (Yield 78%, MS: [M+H]+= 461)
제조예 30Production Example 30
화합물 EB의 제조Preparation of compound EB
상기 제조예 29에서 출발 물질로 DA_P2 대신 DB_P2를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 EB를 13.8g 제조하였다. (수율 74%, MS: [M+H]+= 461)13.8 g of compound EB was prepared in the same manner as in Preparation Example 29, except that DB_P2 was used instead of DA_P2 as a starting material in Preparation Example 29. (Yield 74%, MS: [M+H]+= 461)
제조예 31Preparation Example 31
화합물 EC의 제조Preparation of compound EC
상기 제조예 29에서 출발 물질로 DA_P2 대신 DC_P3를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 EC를 13.3g 제조하였다. (수율 71%, MS: [M+H]+= 461)13.3 g of compound EC was prepared in the same manner as in Preparation Example 29, except that DC_P3 was used instead of DA_P2 as a starting material in Preparation Example 29. (Yield 71%, MS: [M+H]+= 461)
제조예 32Preparation Example 32
화합물 ED의 제조Preparation of Compound ED
상기 제조예 29에서 출발 물질로 DA_P2 대신 DD_P1를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 ED를 14.4g 제조하였다. (수율 77%, MS: [M+H]+= 461)14.4 g of compound ED was prepared in the same manner as in Preparation Example 29, except that DD_P1 was used instead of DA_P2 as a starting material in Preparation Example 29. (Yield 77%, MS: [M+H]+= 461)
제조예 33Preparation Example 33
화합물 EE의 제조Preparation of compound EE
상기 제조예 29에서 출발 물질로 DA_P2 대신 DE_P2를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 EE를 13.5g 제조하였다. (수율 72%, MS: [M+H]+= 461)13.5g of compound EE was prepared in the same manner as in Preparation Example 29, except that DE_P2 was used instead of DA_P2 as a starting material in Preparation Example 29. (Yield 72%, MS: [M+H]+= 461)
제조예 34Preparation Example 34
화합물 EF의 제조Preparation of compound EF
상기 제조예 29에서 출발 물질로 DA_P2 대신 DF_P2를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 EF를 12g 제조하였다. (수율 64%, MS: [M+H]+= 461)12g of compound EF was prepared in the same manner as in Preparation Example 29, except that DF_P2 was used instead of DA_P2 as a starting material in Preparation Example 29. (Yield 64%, MS: [M+H]+= 461)
제조예 35Production Example 35
화합물 EG의 제조Preparation of compound EG
상기 제조예 29에서 출발 물질로 DA_P2 대신 DG_P2를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 EG를 13.3g 제조하였다. (수율 71%, MS: [M+H]+= 461)13.3 g of compound EG was prepared in the same manner as in Preparation Example 29, except that DG_P2 was used instead of DA_P2 as a starting material in Preparation Example 29. (Yield 71%, MS: [M+H]+= 461)
제조예 36Preparation Example 36
화합물 FA의 제조Preparation of compound FA
상기 제조예 29에서 출발 물질로 sub15 대신 sub16를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 FA를 13.5g 제조하였다. (수율 72%, MS: [M+H]+= 461)13.5 g of compound FA was prepared in the same manner as in Preparation Example 29, except that sub16 was used instead of sub15 as a starting material in Preparation Example 29. (Yield 72%, MS: [M+H]+= 461)
제조예 37Preparation Example 37
화합물 FB의 제조Preparation of compound FB
상기 제조예 29에서 출발 물질로 DA_P2대신 DB_P2를 사용하고, sub15 대신 sub16를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 FB를 13.8g 제조하였다. (수율 74%, MS: [M+H]+= 461)13.8 g of compound FB was prepared in the same manner as in Preparation Example 29, except that DB_P2 was used instead of DA_P2 as a starting material and sub16 was used instead of sub15 in Preparation Example 29. (Yield 74%, MS: [M+H]+= 461)
제조예 38Production Example 38
화합물 FC의 제조Preparation of compound FC
상기 제조예 29에서 출발 물질로 DA_P2대신 DC_P3를 사용하고, sub15 대신 sub16를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 FC를 15g 제조하였다. (수율 80%, MS: [M+H]+= 461)15 g of compound FC was prepared in the same manner as in Preparation Example 29, except that DC_P3 was used instead of DA_P2 as a starting material and sub16 was used instead of sub15 in Preparation Example 29. (Yield 80%, MS: [M+H]+= 461)
제조예 39Preparation Example 39
화합물 FD의 제조Preparation of compound FD
상기 제조예 29에서 출발 물질로 DA_P2대신 DD_P1를 사용하고, sub15 대신 sub16를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 FD를 14.6g 제조하였다. (수율 78%, MS: [M+H]+= 461)14.6g of Compound FD was prepared in the same manner as in Preparation Example 29, except that DD_P1 was used instead of DA_P2 as a starting material and sub16 was used instead of sub15 in Preparation Example 29. (Yield 78%, MS: [M+H]+= 461)
제조예 40Production Example 40
화합물 FE의 제조Preparation of compound FE
상기 제조예 29에서 출발 물질로 DA_P2대신 DE_P2를 사용하고, sub15 대신 sub16를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 FE를 15g 제조하였다. (수율 80%, MS: [M+H]+= 461)15 g of compound FE was prepared in the same manner as in Preparation Example 29, except that DE_P2 was used instead of DA_P2 as a starting material and sub16 was used instead of sub15 in Preparation Example 29. (Yield 80%, MS: [M+H]+= 461)
제조예 41Preparation Example 41
화합물 FF의 제조Preparation of compound FF
상기 제조예 29에서 출발 물질로 DA_P2대신 DF_P2를 사용하고, sub15 대신 sub16를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 FF를 12.5g 제조하였다. (수율 67%, MS: [M+H]+= 461)12.5 g of compound FF was prepared in the same manner as in Preparation Example 29, except that DF_P2 was used instead of DA_P2 as a starting material and sub16 was used instead of sub15 in Preparation Example 29. (Yield 67%, MS: [M+H]+= 461)
제조예 42Production Example 42
화합물 FG의 제조Preparation of compound FG
상기 제조예 29에서 출발 물질로 DA_P2대신 DG_P2를 사용하고, sub15 대신 sub16를 사용한 것을 제외하고는, 제조예 29와 동일한 방법을 사용하여 화합물 FG를 13.3g 제조하였다. (수율 71%, MS: [M+H]+= 461)13.3 g of compound FG was prepared in the same manner as in Preparation Example 29, except that DG_P2 was used instead of DA_P2 as a starting material and sub16 was used instead of sub15 in Preparation Example 29. (Yield 71%, MS: [M+H]+= 461)
합성예 1Synthesis Example 1
질소 분위기에서 화학식 AA (10g, 22.5mmol)와 Trz1 (6.1g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 1를 9.6g 제조하였다. (수율 78%, MS: [M+H]+= 550)Formula AA (10g, 22.5mmol) and Trz1 (6.1g, 23mmol) were added to 200ml of THF under nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.6 g of
합성예 2Synthesis Example 2
질소 분위기에서 화학식 AA (10g, 22.5mmol)와 Trz2 (11.3g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 2를 10.6g 제조하였다. (수율 61%, MS: [M+H]+= 776)Formula AA (10g, 22.5mmol) and Trz2 (11.3g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 10.6 g of
합성예 3Synthesis Example 3
질소 분위기에서 화학식 AB (10g, 22.5mmol)와 Trz3 (7.3g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 3를 9.3g 제조하였다. (수율 69%, MS: [M+H]+= 600)Formula AB (10g, 22.5mmol) and Trz3 (7.3g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.3 g of
합성예 4Synthesis Example 4
질소 분위기에서 화학식 AB (10g, 22.5mmol)와 Trz4 (8.6g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 9시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 4를 10g 제조하였다. (수율 68%, MS: [M+H]+= 656)Formula AB (10g, 22.5mmol) and Trz4 (8.6g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 9 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 10 g of
합성예 5Synthesis Example 5
질소 분위기에서 화학식 AB (10g, 22.5mmol)와 Trz5 (9g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 5를 12g 제조하였다. (수율 79%, MS: [M+H]+= 676)Formula AB (10g, 22.5mmol) and Trz5 (9g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12 g of
합성예 6Synthesis Example 6
질소 분위기에서 화학식 AD (10g, 22.5mmol)와 Trz1 (6.1g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 6를 9.4g 제조하였다. (수율 76%, MS: [M+H]+= 550)Formula AD (10g, 22.5mmol) and Trz1 (6.1g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was again dissolved in chloroform, washed twice with water, and the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.4 g of
합성예 7Synthesis Example 7
질소 분위기에서 화학식 AE (10g, 22.5mmol)와 Trz6 (9g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 8시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 7를 9.3g 제조하였다. (수율 61%, MS: [M+H]+= 676)Formula AE (10g, 22.5mmol) and Trz6 (9g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and reflux. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 8 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.3 g of
합성예 8Synthesis Example 8
질소 분위기에서 화학식 AG (10g, 22.5mmol)와 Trz1 (6.1g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 8를 9.4g 제조하였다. (수율 76%, MS: [M+H]+= 550)Formula AG (10g, 22.5mmol) and Trz1 (6.1g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and reflux. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.4 g of
합성예 9Synthesis Example 9
질소 분위기에서 화학식 BA (10g, 22.5mmol)와 Trz7 (9.6g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 9를 12.2g 제조하였다. (수율 77%, MS: [M+H]+= 702)Formula BA (10g, 22.5mmol) and Trz7 (9.6g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere and stirred and refluxed. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.2 g of
합성예 10Synthesis Example 10
질소 분위기에서 화학식 BA (10g, 22.5mmol)와 Trz8 (11.1g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 10를 12.4g 제조하였다. (수율 72%, MS: [M+H]+= 766)Formula BA (10g, 22.5mmol) and Trz8 (11.1g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.4 g of
합성예 11Synthesis Example 11
질소 분위기에서 화학식 BB (10g, 22.5mmol)와 Trz1 (6.1g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 8시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 11를 8.7g 제조하였다. (수율 70%, MS: [M+H]+= 550)Chemical Formula BB (10g, 22.5mmol) and Trz1 (6.1g, 23mmol) were added to 200ml of THF under nitrogen atmosphere and stirred and refluxed. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 8 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.7 g of Compound 11. (Yield 70%, MS: [M+H]+= 550)
합성예 12Synthesis Example 12
질소 분위기에서 화학식 BB (10g, 22.5mmol)와 Trz9 (11.1g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 12를 12.9g 제조하였다. (수율 75%, MS: [M+H]+= 766)Chemical Formula BB (10g, 22.5mmol) and Trz9 (11.1g, 23mmol) were added to 200ml of THF under nitrogen atmosphere and stirred and refluxed. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.9 g of Compound 12. (Yield 75%, MS: [M+H]+= 766)
합성예 13Synthesis Example 13
질소 분위기에서 화학식 BB (10g, 22.5mmol)와 Trz10 (9g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 13를 9.9g 제조하였다. (수율 65%, MS: [M+H]+= 676)BB (10g, 22.5mmol) and Trz10 (9g, 23mmol) were added to 200ml of THF under nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.9 g of Compound 13. (Yield 65%, MS: [M+H]+= 676)
합성예 14Synthesis Example 14
질소 분위기에서 화학식 BD (10g, 22.5mmol)와 Trz11 (7.9g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 14를 10.3g 제조하였다. (수율 73%, MS: [M+H]+= 626)Formula BD (10g, 22.5mmol) and Trz11 (7.9g, 23mmol) were added to 200ml of THF under nitrogen atmosphere, followed by stirring and reflux. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 10.3 g of Compound 14. (Yield 73%, MS: [M+H]+= 626)
합성예 15Synthesis Example 15
질소 분위기에서 화학식 BF (10g, 22.5mmol)와 Trz12 (8.4g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 15를 10.8g 제조하였다. (수율 74%, MS: [M+H]+= 650)Formula BF (10g, 22.5mmol) and Trz12 (8.4g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 10.8 g of Compound 15. (Yield 74%, MS: [M+H]+= 650)
합성예 16Synthesis Example 16
질소 분위기에서 화학식 BG (10g, 22.5mmol)와 Trz13 (8.2g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 9시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 16를 9.5g 제조하였다. (수율 66%, MS: [M+H]+= 639)Chemical Formula BG (10g, 22.5mmol) and Trz13 (8.2g, 23mmol) were added to 200ml of THF and stirred and refluxed in a nitrogen atmosphere. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 9 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.5 g of Compound 16. (Yield 66%, MS: [M+H]+= 639)
합성예 17Synthesis Example 17
질소 분위기에서 화학식 CA (10g, 22.5mmol)와 Trz3 (7.3g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 17를 8.5g 제조하였다. (수율 63%, MS: [M+H]+= 600)Formula CA (10g, 22.5mmol) and Trz3 (7.3g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and reflux. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.5 g of Compound 17. (Yield 63%, MS: [M+H]+= 600)
합성예 18Synthesis Example 18
질소 분위기에서 화학식 CA (10g, 22.5mmol)와 Trz14 (8.2g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 18를 10.6g 제조하였다. (수율 74%, MS: [M+H]+= 640)Formula CA (10g, 22.5mmol) and Trz14 (8.2g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 10.6 g of Compound 18. (Yield 74%, MS: [M+H]+= 640)
합성예 19Synthesis Example 19
질소 분위기에서 화학식 CC (10g, 22.5mmol)와 Trz15 (9g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 19를 12.2g 제조하였다. (수율 80%, MS: [M+H]+= 676)Chemical formula CC (10g, 22.5mmol) and Trz15 (9g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.2 g of Compound 19. (Yield 80%, MS: [M+H]+= 676)
합성예 20Synthesis Example 20
질소 분위기에서 화학식 CC (10g, 22.5mmol)와 Trz16 (9.9g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 20를 12.9g 제조하였다. (수율 80%, MS: [M+H]+= 715)Chemical formula CC (10g, 22.5mmol) and Trz16 (9.9g, 23mmol) were added to 200ml of THF under nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.9 g of Compound 20. (Yield 80%, MS: [M+H]+= 715)
합성예 21Synthesis Example 21
질소 분위기에서 화학식 CD (10g, 22.5mmol)와 Trz17 (10.2g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 21를 13.1g 제조하였다. (수율 80%, MS: [M+H]+= 726)Chemical formula CD (10g, 22.5mmol) and Trz17 (10.2g, 23mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.1 g of Compound 21. (Yield 80%, MS: [M+H]+= 726)
합성예 22Synthesis Example 22
질소 분위기에서 화학식 CD (10g, 22.5mmol)와 Trz18 (10.8g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 9시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 22를 11.2g 제조하였다. (수율 66%, MS: [M+H]+= 752)Chemical formula CD (10g, 22.5mmol) and Trz18 (10.8g, 23mmol) were added to 200ml of THF under nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 9 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 11.2 g of Compound 22. (Yield 66%, MS: [M+H]+= 752)
합성예 23Synthesis Example 23
질소 분위기에서 화학식 CE (10g, 22.5mmol)와 Trz1 (6.1g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 23를 9.6g 제조하였다. (수율 78%, MS: [M+H]+= 550)Chemical Formula CE (10g, 22.5mmol) and Trz1 (6.1g, 23mmol) were added to 200ml of THF and stirred and refluxed in a nitrogen atmosphere. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.6 g of Compound 23. (Yield 78%, MS: [M+H]+= 550)
합성예 24Synthesis Example 24
질소 분위기에서 화학식 CE (10g, 22.5mmol)와 Trz19 (9g, 23mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9.3g, 67.5mmol)를 물 28ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 9시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 24를 11.5g 제조하였다. (수율 76%, MS: [M+H]+= 676)Chemical formula CE (10g, 22.5mmol) and Trz19 (9g, 23mmol) were added to 200ml of THF, stirred and refluxed in a nitrogen atmosphere. Thereafter, potassium carbonate (9.3g, 67.5mmol) was dissolved in 28ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 9 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 11.5 g of Compound 24. (Yield 76%, MS: [M+H]+= 676)
합성예 25Synthesis Example 25
질소 분위기에서 화학식 DA (10g, 21.7mmol)와 Trz20 (9.6g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 25를 10.6g 제조하였다. (수율 67%, MS: [M+H]+= 731)Formula DA (10g, 21.7mmol) and Trz20 (9.6g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 10.6 g of Compound 25. (Yield 67%, MS: [M+H]+= 731)
합성예 26Synthesis Example 26
질소 분위기에서 화학식 DA (10g, 21.7mmol)와 Trz21 (8.7g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 26를 10.7g 제조하였다. (수율 71%, MS: [M+H]+= 692)Formula DA (10g, 21.7mmol) and Trz21 (8.7g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and reflux. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 10.7 g of Compound 26. (Yield 71%, MS: [M+H]+= 692)
합성예 27Synthesis Example 27
질소 분위기에서 화학식 DC (10g, 21.7mmol)와 Trz21 (8.3g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 27를 9.2g 제조하였다. (수율 63%, MS: [M+H]+= 672)Formula DC (10g, 21.7mmol) and Trz21 (8.3g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and reflux. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.2 g of Compound 27. (Yield 63%, MS: [M+H]+= 672)
합성예 28Synthesis Example 28
질소 분위기에서 화학식 DD (10g, 21.7mmol)와 Trz11 (7.6g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 8시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 28를 8.4g 제조하였다. (수율 60%, MS: [M+H]+= 642)Formula DD (10g, 21.7mmol) and Trz11 (7.6g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 8 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.4 g of Compound 28. (Yield 60%, MS: [M+H]+= 642)
합성예 29Synthesis Example 29
질소 분위기에서 화학식 DE (10g, 21.7mmol)와 Trz23 (9.3g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 29를 11.3g 제조하였다. (수율 73%, MS: [M+H]+= 716)Formula DE (10g, 21.7mmol) and Trz23 (9.3g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 11.3 g of Compound 29. (Yield 73%, MS: [M+H]+= 716)
합성예 30Synthesis Example 30
질소 분위기에서 화학식 DF (10g, 21.7mmol)와 Trz3 (7g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 30를 8.2g 제조하였다. (수율 61%, MS: [M+H]+= 616)DF (10 g, 21.7 mmol) and Trz3 (7 g, 22.2 mmol) were added to 200 ml of THF under a nitrogen atmosphere, followed by stirring and reflux. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.2 g of Compound 30. (Yield 61%, MS: [M+H]+= 616)
합성예 31Synthesis Example 31
질소 분위기에서 화학식 DG (10g, 21.7mmol)와 Trz24 (8.7g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 31를 9.8g 제조하였다. (수율 65%, MS: [M+H]+= 692)Formula DG (10g, 21.7mmol) and Trz24 (8.7g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.8 g of Compound 31. (Yield 65%, MS: [M+H]+= 692)
합성예 32Synthesis Example 32
질소 분위기에서 화학식 EA (10g, 21.7mmol)와 Trz1 (5.9g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 32를 9.3g 제조하였다. (수율 76%, MS: [M+H]+= 566)Formula EA (10g, 21.7mmol) and Trz1 (5.9g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.3 g of Compound 32. (Yield 76%, MS: [M+H]+= 566)
합성예 33Synthesis Example 33
질소 분위기에서 화학식 EA (10g, 21.7mmol)와 Trz25 (7.9g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 33를 9.7g 제조하였다. (수율 68%, MS: [M+H]+= 656)Formula EA (10g, 21.7mmol) and Trz25 (7.9g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.7 g of Compound 33. (Yield 68%, MS: [M+H]+= 656)
합성예 34Synthesis Example 34
질소 분위기에서 화학식 EC (10g, 21.7mmol)와 Trz26 (8.1g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 9시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 34를 11g 제조하였다. (수율 76%, MS: [M+H]+= 666)Formula EC (10g, 21.7mmol) and Trz26 (8.1g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and reflux. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 9 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 11 g of Compound 34. (Yield 76%, MS: [M+H]+= 666)
합성예 35Synthesis Example 35
질소 분위기에서 화학식 ED (10g, 21.7mmol)와 Trz1 (5.9g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 35를 9.8g 제조하였다. (수율 80%, MS: [M+H]+= 566)Formula ED (10g, 21.7mmol) and Trz1 (5.9g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.8 g of Compound 35. (Yield 80%, MS: [M+H]+= 566)
합성예 36Synthesis Example 36
질소 분위기에서 화학식 EF (10g, 21.7mmol)와 Trz27 (7.6g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 36를 11g 제조하였다. (수율 79%, MS: [M+H]+= 642)Formula EF (10g, 21.7mmol) and Trz27 (7.6g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 11 g of compound 36. (Yield 79%, MS: [M+H]+= 642)
합성예 37Synthesis Example 37
질소 분위기에서 화학식 EG (10g, 21.7mmol)와 Trz1 (5.9g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 12시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 37를 7.9g 제조하였다. (수율 64%, MS: [M+H]+= 566)Formula EG (10g, 21.7mmol) and Trz1 (5.9g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 12 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.9 g of Compound 37. (Yield 64%, MS: [M+H]+= 566)
합성예 38Synthesis Example 38
질소 분위기에서 화학식 FB (10g, 21.7mmol)와 Trz11 (7.6g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 10시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 38를 10.3g 제조하였다. (수율 74%, MS: [M+H]+= 642)Formula FB (10g, 21.7mmol) and Trz11 (7.6g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 10 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 10.3 g of Compound 38. (Yield 74%, MS: [M+H]+= 642)
합성예 39Synthesis Example 39
질소 분위기에서 화학식 FC (10g, 21.7mmol)와 Trz1 (5.9g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 9시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 39를 8.7g 제조하였다. (수율 71%, MS: [M+H]+= 566)Chemical formula FC (10g, 21.7mmol) and Trz1 (5.9g, 22.2mmol) were added to 200ml of THF, stirred and refluxed in a nitrogen atmosphere. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 9 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.7 g of Compound 39. (Yield 71%, MS: [M+H]+= 566)
합성예 40Synthesis Example 40
질소 분위기에서 화학식 FE (10g, 21.7mmol)와 Trz28 (9.3g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 9시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 40를 11.4g 제조하였다. (수율 73%, MS: [M+H]+= 718)Formula FE (10g, 21.7mmol) and Trz28 (9.3g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 9 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 11.4 g of Compound 40. (Yield 73%, MS: [M+H]+= 718)
합성예 41Synthesis Example 41
질소 분위기에서 화학식 FE (10g, 21.7mmol)와 Trz29 (9.3g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 11시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 41를 10.6g 제조하였다. (수율 68%, MS: [M+H]+= 718)Formula FE (10g, 21.7mmol) and Trz29 (9.3g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 11 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 10.6 g of Compound 41. (Yield 68%, MS: [M+H]+= 718)
합성예 42Synthesis Example 42
질소 분위기에서 화학식 FG (10g, 21.7mmol)와 Trz1 (5.9g, 22.2mmol)를 THF 200ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(9g, 65.2mmol)를 물 27ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol)을 투입하였다. 9시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 42를 9.7g 제조하였다. (수율 79%, MS: [M+H]+= 566)Formula FG (10g, 21.7mmol) and Trz1 (5.9g, 22.2mmol) were added to 200ml of THF under a nitrogen atmosphere, followed by stirring and refluxing. Thereafter, potassium carbonate (9g, 65.2mmol) was dissolved in 27ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.1g, 0.2mmol) was added. After reacting for 9 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.7 g of Compound 42. (Yield 79%, MS: [M+H]+= 566)
실시예 1Example 1
ITO(indium tin oxide)가 1,000Å의 두께로 박막 코팅된 유리 기판을 세제를 녹인 증류수에 넣고 초음파로 세척했다. 이때, 세제로는 피셔사(Fischer Co.) 제품을 사용하였으며, 증류수로는 밀러포어사(Millipore Co.) 제품의 필터(Filter)로 2차로 걸러진 증류수를 사용했다. ITO를 30분간 세척한 후 증류수로 2회 반복하여 초음파 세척을 10분간 진행했다. 증류수 세척이 끝난 후, 이소프로필알콜, 아세톤, 메탄올의 용제로 초음파 세척을 하고 건조시킨 후 플라즈마 세정기로 수송시켰다. 또한, 산소 플라즈마를 이용하여 상기 기판을 5분간 세정한 후 진공 증착기로 기판을 수송시켰다.A glass substrate coated with ITO (indium tin oxide) to a thickness of 1,000 Å was put in distilled water in which detergent was dissolved and washed with ultrasonic waves. At this time, a Fischer Co. product was used as the detergent, and distilled water filtered through a second filter of a Millipore Co. product was used as the distilled water. After washing the ITO for 30 minutes, it was repeated twice with distilled water and ultrasonic cleaning was performed for 10 minutes. After washing with distilled water, ultrasonic cleaning was performed with solvents such as isopropyl alcohol, acetone, and methanol, dried, and transported to a plasma cleaner. In addition, after cleaning the substrate for 5 minutes using oxygen plasma, the substrate was transferred to a vacuum deposition machine.
이렇게 준비된 ITO 투명 전극 위에 정공주입층으로 하기 HI-1 화합물을 1150Å의 두께로 형성하되 하기 A-1 화합물을 1.5% 농도로 p-doping 했다. 상기 정공주입층 위에 하기 HT-1 화합물을 진공 증착하여 막 두께 800Å의 정공수송층을 형성했다. 이어서, 상기 정공수송층 위에 막 두께 150Å으로 하기 EB-1 화합물을 진공 증착하여 전자억제층을 형성했다. 이어서, 상기 전자억제층 위에 호스트로서 상기 합성예 1에서 제조한 화합물 1과 도펀트로서 하기 Dp-7 화합물을 98:2의 중량비로 진공 증착하여 400Å 두께의 적색 발광층을 형성했다. 상기 발광층 위에 막 두께 30Å으로 하기 HB-1 화합물을 진공 증착하여 정공저지층을 형성했다. 이어서, 상기 정공저지층 위에 하기 ET-1 화합물과 하기 LiQ 화합물을 2:1의 중량비로 진공 증착하여 300Å의 두께로 전자 주입 및 수송층을 형성했다. 상기 전자 주입 및 수송층 위에 순차적으로 12Å 두께로 리튬플로라이드(LiF)와 1,000Å 두께로 알루미늄을 증착하여 음극을 형성했다. The following compound HI-1 was formed to a thickness of 1150 Å as a hole injection layer on the prepared ITO transparent electrode, but the following compound A-1 was p-doped at a concentration of 1.5%. On the hole injection layer, the following HT-1 compound was vacuum deposited to form a hole transport layer having a thickness of 800 Å. Subsequently, an electron blocking layer was formed on the hole transport layer by vacuum depositing the following EB-1 compound to a film thickness of 150 Å. Subsequently,
상기의 과정에서 유기물의 증착속도는 0.4~0.7Å/sec를 유지하였고, 음극의 리튬플로라이드는 0.3Å/sec, 알루미늄은 2Å/sec의 증착 속도를 유지하였으며, 증착시 진공도는 2ⅹ10-7 ~ 5ⅹ10-6 torr를 유지하여, 유기 발광 소자를 제작했다. In the above process, the deposition rate of the organic material was maintained at 0.4 ~ 0.7Å / sec, the deposition rate of lithium fluoride on the cathode was 0.3Å / sec, and the deposition rate of aluminum was 2Å / sec, and the vacuum level during deposition was 2ⅹ10 -7 ~ While maintaining 5x10 -6 torr, an organic light emitting device was fabricated.
실시예 2 내지 42Examples 2 to 42
실시예 1의 유기 발광 소자에서 화합물 1 대신에 하기 표 1에 기재된 화합물을 사용하는 것을 제외하고는, 상기 실시예 1과 동일한 방법으로 유기 발광 소자를 제조했다. An organic light emitting device was manufactured in the same manner as in Example 1, except that the compound shown in Table 1 was used instead of
비교예 1 내지 6Comparative Examples 1 to 6
실시예 1의 유기 발광 소자에서 화합물 1 대신에 하기 표 1에 기재된 화합물을 사용하는 것을 제외하고는, 상기 실시예 1과 동일한 방법으로 유기 발광 소자를 제조했다. An organic light emitting device was manufactured in the same manner as in Example 1, except that the compound shown in Table 1 was used instead of
실험예Experimental example
상기 실시예 1 내지 42, 및 비교예 1 내지 6에서 제조한 유기 발광 소자에 전류 10mA/cm2를 인가하였을 때, 구동 전압 및 효율을 각각 측정하고 그 결과를 하기 표 1에 나타냈다. 또, 수명 T95는 휘도가 초기 휘도(6000 nit)에서 95%로 감소되는데 소요되는 시간을 의미한다.When a current of 10 mA/cm 2 was applied to the organic light emitting devices prepared in Examples 1 to 42 and Comparative Examples 1 to 6, driving voltage and efficiency were measured, respectively, and the results are shown in Table 1 below. Also, the lifetime T95 means the time required for the luminance to decrease from the initial luminance (6000 nit) to 95%.
실험결과, 본 발명에 따른 화합물을 발광층에 사용한 실시예들의 유기 발광 소자는, 비교예와 비교하여 구동 전압이 크게 낮아졌으며, 효율 측면에도 크게 상승하였다. 이로부터 호스트에서 적색 도판트로의 에너지 전달이 잘 이루어졌음을 알 수 있다. 또한 실시예의 유기 발광 소자는 비교예와 비교하여 높은 효율을 유지하면서도 크게 개선된 수명 특성을 나타내었으며, 이는 비교예에서 사용된 화합물 보다 본 발명의 화합물이 전자와 정공에 대한 안정도가 높기 때문이라 판단된다.As a result of the experiment, the organic light emitting devices of the examples using the compound according to the present invention in the light emitting layer had significantly lowered driving voltage and significantly increased efficiency compared to the comparative example. From this, it can be seen that energy transfer from the host to the red dopant was well performed. In addition, the organic light emitting device of Examples exhibited significantly improved lifespan characteristics while maintaining high efficiency compared to Comparative Examples, which is determined because the compounds of the present invention have higher stability to electrons and holes than the compounds used in Comparative Examples. do.
결론적으로 본 발명의 화합물을 적색 발광층의 호스트로 사용하였을 때 유기 발광 소자의 구동전압, 발광 효율 및 수명 특성을 개선할 수 있다는 것을 확인할 수 있으며, 이는 일반적으로 유기 발광 소자의 발광 효율 및 수명 특성은 서로 트레이드-오프(Trade-off) 관계를 갖는 점을 고려할 때 실시예의 유기 발광 소자는 비교예 소자 대비 현저히 향상된 소자 특성을 나타낸다고 볼 수 있다.In conclusion, it can be confirmed that when the compound of the present invention is used as a host of a red light emitting layer, the driving voltage, luminous efficiency and lifespan characteristics of an organic light emitting device can be improved. Considering that they have a trade-off relationship with each other, it can be seen that the organic light emitting devices of Examples exhibit significantly improved device characteristics compared to the devices of Comparative Examples.
1: 기판 2: 양극
3: 유기물 층 4: 음극
5: 정공주입층 6: 정공수송층
7: 전자억제층 8: 발광층
9: 정공저지층 10: 전자 주입 및 수송층 1: substrate 2: anode
3: organic layer 4: cathode
5: hole injection layer 6: hole transport layer
7: electron suppression layer 8: light emitting layer
9: hole blocking layer 10: electron injection and transport layer
Claims (10)
[화학식 1]
상기 화학식 1에서,
X는 O 또는 S이고,
A는 인접한 두 개의 고리와 융합된 벤젠 고리이고,
R1 내지 R8 중 어느 하나는 하기 화학식 2로 표시되고, 나머지는 각각 독립적으로 CH 또는 CD이며,
R은 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 C1-60 알킬; 또는 치환 또는 비치환된 C6-60 아릴이며,
n은 0 내지 6의 정수이고,
[화학식 2]
상기 화학식 2에서,
L은 단일 결합; 또는 치환 또는 비치환된 C6-60 아릴렌이고,
Y는 각각 독립적으로 N 또는 CH이되, 단 Y중 적어도 2개는 N이고,
Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6-60 아릴; 또는 치환 또는 비치환된, N, O 및 S로 구성되는 군으로부터 선택되는 어느 하나 이상을 포함하는 C5-60 헤테로아릴이며,
점선은 결합 위치를 나타낸다.
A compound represented by Formula 1 below:
[Formula 1]
In Formula 1,
X is O or S;
A is a benzene ring fused with two adjacent rings,
Any one of R 1 to R 8 is represented by the following formula (2), and the others are each independently CH or CD,
R are each independently hydrogen; heavy hydrogen; Substituted or unsubstituted C 1-60 Alkyl; Or a substituted or unsubstituted C 6-60 aryl,
n is an integer from 0 to 6;
[Formula 2]
In Formula 2,
L is a single bond; Or a substituted or unsubstituted C 6-60 arylene,
Y is each independently N or CH, provided that at least two of Y are N,
Ar 1 and Ar 2 are each independently a substituted or unsubstituted C 6-60 aryl; Or a substituted or unsubstituted, C 5-60 heteroaryl containing at least one selected from the group consisting of N, O and S,
Dotted lines indicate binding sites.
상기 화학식 1은 하기 화학식 1-1 내지 1-3 중 어느 하나인,
화합물:
[화학식 1-1]
[화학식 1-2]
[화학식 1-3]
상기 화학식 1-1 내지 1-3에 있어서,
X, R1 내지 R8, R, 및 n는 제1항에서 정의한 바와 같다.
According to claim 1,
Formula 1 is any one of the following Formulas 1-1 to 1-3,
compound:
[Formula 1-1]
[Formula 1-2]
[Formula 1-3]
In Formulas 1-1 to 1-3,
X, R 1 to R 8 , R, and n are as defined in claim 1.
L은 단일 결합, 페닐렌, 또는 나프틸렌인,
화합물.
According to claim 1,
L is a single bond, phenylene, or naphthylene;
compound.
Y는 모두 N인,
화합물.
According to claim 1,
Y is all N,
compound.
Ar1 및 Ar2는 각각 독립적으로 C6-30 아릴; 또는 N, O 또는 S를 포함하는 C5-30 헤테로아릴이며,
상기 Ar1 및 Ar2는 각각 독립적으로 하나 이상의 중수소, C1-20 알킬 또는 C6-20 아릴로 치환되거나, 또는 비치환되는,
화합물.
According to claim 1,
Ar 1 and Ar 2 are each independently C 6-30 aryl; or C 5-30 heteroaryl containing N, O or S;
Wherein Ar 1 and Ar 2 are each independently substituted with one or more deuterium, C 1-20 alkyl or C 6-20 aryl, or unsubstituted;
compound.
Ar1 및 Ar2는 각각 독립적으로 페닐, 비페닐, 터페닐, 나프틸, 페난쓰레닐, 트리페닐레닐, 플루오란테닐, (나프틸)페닐, (페닐)나프틸, 플루오레닐, 디벤조퓨라닐, 디벤조티오펜일 또는 카르바졸일이며,
상기 Ar1 및 Ar2는 각각 독립적으로 하나 이상의 중수소, C1-18 알킬, 또는 C6-18 아릴로 치환되거나 또는 비치환되는,
화합물.
According to claim 1,
Ar 1 and Ar 2 are each independently phenyl, biphenyl, terphenyl, naphthyl, phenanthrenyl, triphenylenyl, fluoranthenyl, (naphthyl)phenyl, (phenyl)naphthyl, fluorenyl, dibenzo furanyl, dibenzothiophenyl or carbazolyl;
Wherein Ar 1 and Ar 2 are each independently one or more deuterium, C 1-18 alkyl, or C 6-18 aryl unsubstituted or substituted,
compound.
Ar1 및 Ar2는 중 어느 하나는 페닐, 비페닐 또는 나프틸이고,
나머지는 페닐, 비페닐, 터페닐, 나프틸, 페난쓰레닐, 트리페닐레닐, 플루오란테닐, (나프틸)페닐, (페닐)나프틸, 플루오레닐, 디벤조퓨라닐, 디벤조티오펜일, 또는 카르바졸일이며,
상기 Ar1 및 Ar2는 각각 독립적으로 하나 이상의 중수소, 메틸, 또는 페닐로 치환되거나 또는 비치환되는,
화합물.
According to claim 1,
Any one of Ar 1 and Ar 2 is phenyl, biphenyl or naphthyl;
The rest are phenyl, biphenyl, terphenyl, naphthyl, phenanthrenyl, triphenylenyl, fluoranthenyl, (naphthyl)phenyl, (phenyl)naphthyl, fluorenyl, dibenzofuranyl, dibenzothiophene one, or carbazolyl;
Ar 1 and Ar 2 are each independently unsubstituted or substituted with one or more deuterium, methyl, or phenyl;
compound.
R은 각각 독립적으로 수소 또는 중수소인,
화합물.
According to claim 1,
R are each independently hydrogen or deuterium,
compound.
상기 화학식 1로 표시되는 화합물은 하기로 구성되는 군으로부터 선택되는 어느 하나인,
화합물:
.
According to claim 1,
The compound represented by Formula 1 is any one selected from the group consisting of
compound:
.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200057326 | 2020-05-13 | ||
KR1020200057326 | 2020-05-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210139185A KR20210139185A (en) | 2021-11-22 |
KR102479341B1 true KR102479341B1 (en) | 2022-12-20 |
Family
ID=78717866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210061611A KR102479341B1 (en) | 2020-05-13 | 2021-05-12 | Novel compound and organic light emitting device comprising the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102479341B1 (en) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100430549B1 (en) | 1999-01-27 | 2004-05-10 | 주식회사 엘지화학 | New organomattalic complex molecule for the fabrication of organic light emitting diodes |
KR102270082B1 (en) * | 2014-09-05 | 2021-06-29 | 삼성디스플레이 주식회사 | Condensed-cyclic compound and organic light emitting diode comprising the same |
KR102458684B1 (en) * | 2015-10-08 | 2022-10-26 | 삼성디스플레이 주식회사 | Organic light emitting device |
KR102292768B1 (en) * | 2015-10-13 | 2021-08-25 | 롬엔드하스전자재료코리아유한회사 | Organic Electroluminescent Compounds and Organic Electroluminescent Devices Comprising the Same |
KR20180024306A (en) * | 2016-08-29 | 2018-03-08 | 에스에프씨 주식회사 | Novel organic compounds and organic light-emitting diode therewith |
KR102642183B1 (en) * | 2016-09-20 | 2024-02-29 | 에스에프씨 주식회사 | Novel organic compounds and organic light-emitting diode therewith |
KR102613183B1 (en) * | 2017-02-28 | 2023-12-14 | 롬엔드하스전자재료코리아유한회사 | Organic electroluminescent device |
KR102486441B1 (en) * | 2017-12-28 | 2023-01-06 | 엘지디스플레이 주식회사 | Organic light emitting diode |
-
2021
- 2021-05-12 KR KR1020210061611A patent/KR102479341B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20210139185A (en) | 2021-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102602156B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR20210036304A (en) | Novel compound and organic light emitting device comprising the same | |
KR20210020843A (en) | Novel compound and organic light emitting device comprising the same | |
KR20210047819A (en) | Novel compound and organic light emitting device comprising the same | |
KR20210045944A (en) | Novel compound and organic light emitting device comprising the same | |
KR20210031380A (en) | Novel compound and organic light emitting device comprising the same | |
KR102437748B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR20210090468A (en) | Novel compound and organic light emitting device comprising the same | |
KR102437747B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102537419B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102521059B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102511932B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102564847B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102437746B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102424910B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR20210012958A (en) | Novel compound and organic light emitting device comprising the same | |
KR102479341B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR20210115596A (en) | Novel compound and organic light emitting device comprising the same | |
KR102478095B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102479342B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102500850B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102529931B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102549460B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102486519B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR20230053530A (en) | Novel compound and organic light emitting device comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right |